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1. Introduction 
1.1. Crystallopathies 
 
Deposits of crystals in the body can lead to tissue injury and even organ failure. The term 
crystals refers to solid materials composed of atoms, molecules, or irons. However, in living 
organisms, the formation of crystals can also result in aggregation of atoms and ions, which in 
turn can built more complex structures like bones, teeth, and shells. Sometimes the formation 
of crystals could lead to injury. For instance, crystals sticking together can form poly-
crystalline masses up to calculi, leading to kidney damage. The supersaturation of calcium 
oxalate (CaOx) or calcium phosphate (CaP) inside the tubular compartment of the kidney can 
result in the formation of kidney stone, which manifest as nephrocalcinosis tubular injury and 
chronic kidney disease (CKD) (Table 1).4 Many studies have shown an increase in the 
prevalence and incidence of nephrolithiasis over the last several decades. Kidney stones disease 
affects all populations, with a prevalence of around 15% worldwide.5 The aggregation of 
cholesterol crystals inside arteries' walls can form a plaque resulting in atherosclerosis and 
cardiovascular diseases.6 The clinical manifestations involve ischemic stroke, myocardial 
infarction, cholesterol embolism, and peripheral arterial disease.7 The mortality rate of 
cardiovascular diseases is 17.9 million each year 8, according to World Health Organization 
(WHO). Smoking is the most significant risk for chronic obstructive pulmonary disease 
(COPD). Smoking a cigarette exposes the human respiratory tract to between 15,000 and 
40,000 μg particulate matter (PM)9, resulting in oxidative stress and tissue injury. Cigarette 
smoking is considered as air pollution and responsible for 480,000 deaths per year in the United 
States, according to the WHO. In addition, other environmental and occupational air pollutions 
are associated with PM exposure to the human body. For example, silicosis is an occupational 
lung disease, which is caused by inhalation of crystalline silica particles leading to lung injury. 
Coal workers' pneumoconiosis is associated with prolonged exposure to the coal dust, diesel 
exhaust particulate matters are composed of carbonaceous combustion could increase the risk 
of lung cancer 10, and burning of biomass is associated with an acute respiratory infections.11 
According to the Nations Environment Programme (UNEP) web site, outdoor air pollution is 
responsible for 25% of all deaths, disease from lung cancer is 17% of all deaths, disease from 
an acute lower respiratory infection is 16% of all deaths, disease from stroke 15% of all deaths, 
and disease from ischaemic heart disease 8% of all deaths and disease from chronic obstructive 
pulmonary disease.12 A study describes that inhaling particulate air pollution could result in 
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brain tissue damage in children.13 According to the WHO air quality database, 97% of cities in 
low-and middle-income countries with a population of more than 100,000 do not meet the air 
quality guidelines. For example, Delhi, India, and Cairo, Egypt have the worst PM10 pollution 
levels. Also, Argentina, Brazil, China, Mexico, and Turkey are in the top ten list of the most-
polluted countries. The air pollution in Tehran (the capital city of Iran) and Shiraz (one of the 
big cities in Iran) is above the threshold provided by the WHO air quality guidelines and are 
thought to cause 28,079 deaths per year in both cities. Therefore, there is an urgent medical 
need to find better therapies for crystal-related diseases. This requires to first identifying the 
molecular mechanisms of crystal or crystalline particle-related diseases. The crystal-related 
diseases can be found in table 1. 
1.1.1. Crystal or crystalline particles related to kidney diseases 
 
The deposition of crystalline particles into the kidney can be divided into three types.  
Cholesterol crystals deposit into renal vascular or vascular calcification (Type 1), deposition 
of crystalline particles such as CaP, myoglobin, and cysteine inside or outside of tubular cells 
lead to tubular injury (Type 2) and deposition of crystal particles like CaOx and MSU into 
ureter cause urolithiasis or kidney stones (Type 3).14 Type 1 crystalline nephropathy is 
associated with renal cholesterol embolism.14 The source of cholesterol crystals are 
atherosclerotic plaques, which can rupture spontaneously upon trauma or during 
anticoagulation therapy.15 Different organs can be affected by cholesterol embolism such as 
the kidneys, gastrointestinal tract, skin, skeletal muscles, and brain.14,15 Cholesterol crystals 
can directly induce cell death in renal epithelial tubular cells by activating RIPK3 and 
MLKL.16,1 In addition, they can trigger inflammation. For example, macrophages take up 
cholesterol crystals and activate the NLRP3 inflammasome, which leads to the release of IL-
1β and other cytokines. Type 2 crystalline nephropathy mainly relates to tubular injury, which 
can present as acute kidney injury (AKI) or CKD. AKI is a result of acute supersaturation, 
which induces a sudden crystal formation leading to acute crystal-induced tubular cell injury, 
inflammation, and kidney failure.14 However, mild supersaturation can cause crystal formation 
over long periods, which can result in tissue remodelling, tubule obstruction, and CKD. For 
instance, in monoclonal gammopathies, the immunoglobulin light chains form crystals in the 
lumen of the proximal tubules depending on their physicochemical properties.17 
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Table 1: Crystal or crystalline particle-related diseases 
Crystalline particles Disorder Clinical manifestation 
Intrinsic inorganic crystals 
Brushite   Cholecystolithiasis/docholithiasis Renal colic 
Calcium carbonate   Cholecystolithiasis/docholithiasis 
Nephrolithiasis/urolithiasis 
Biliary colic 
Renal colic 
Calcium-oxalate monohydrate 
(whewellite)/ 
Calcium-oxalate  
dihydrate (weddellite) 
Nephrolithiasis/urolithiasis 
Acute oxalate nephropathy 
  Polyethelene glycol poisoning 
  Dietary oxalosis: Black tea, star  
  fruit, rhubarb, vitamin C, nuts 
  Bariatric surgery-/short bowl- 
  related 
  Chronic oxalate nephropathy 
  Primary hyperoxaluria   
Renal colic 
Acute kidney injury  
Acute kidney injury  
Acute kidney injury, renal colic 
 
Acute kidney injury, renal colic 
 
Chronic kidney disease 
CKD, organ oxalosis   
Calcium pyrophosphate 
/Calcium phosphate 
Pseudogout, chondrocalcinosis, 
Hemochromatosis, 
hyperparathyroidism, 
Vascular calcification, calciphylaxis 
Warfarin calcification 
Dent`s disease, Nephrocalcinosis 
Acute monarthritis, periarthritis, bursitis 
 
 
Tissue ischemia, ischemic necrosis 
Tissue ischemia, ischemic necrosis 
Nephrocalcinosis 
Intrinsic organic crystals or microparticles 
Adenine Adenine phosphoribosyltransferase 
deficiency 
Nephrolithiasis/urolithiasis, renal colic, 
chronic kidney disease 
Amyloid Amyloid-β in Alzheimer disease 
Amylin in diabetes 
Dementia 
Hyperglycemia 
Bile pigment Cholecysto-/docholithiasis 
Cholecysto-/docholithiasis 
Biliary colic, pancreatitis 
Acute kidney injury 
Cholesterol Atherosclerosis 
Cholesterol embolism 
Nonalcoholic steatohepatitis 
Cholesteryl ester storage disease 
Cholesterol granuloma 
Cholecysto-/docholithiasis 
Tissue ischemia, ischemic necrosis  
Ischemic necrosis 
Acute lipotoxic liver disease 
Chronic lipotoxic live disease 
Bone lesions 
Biliary colic 
Cystine Cystinosis CKD, urolithiasis, extrarenal   
Light chains Myeloma cast nephropathy  
Crystalloglobulinemia 
Light chain Fanconi syndrome 
Crystal-storing histiocytosis 
Fibrillary glomerulonephritis 
Immunotactoid glomerulopathy 
Acute kidney injury  
Thrombotic microangiopathy 
Renal tubulopathy, CKD  
Renal tubulopathy, CKD 
Proteinuria, CKD 
Proteinuria, CKD 
MSU Gout 
 
Nephrolithiasis or urolithiasis  
Urate nephropathy 
Acute monoarthritis, bursitis, chronic 
tophous gout 
Renal colic 
Acute kidney injury 
Myoglobin Myoglobin cast nephropathy Acute kidney injury 
Uromodulin Cast nephropathies Acute kidney injury 
Extrinsic crystals or particulates 
Asbestos Lung asbestosis, malignancy Pulmonary fibrosis, mesothelioma 
Drugs(acyclovir,methotrexate, 
indinavir, sulfadiazine) 
Drug-related kidney injury Acute kidney injury, renal colic 
Hemozoin Malaria Hemolysis, SIRS 
Implants, implant debris 
particles 
Implant-related injury 
 
Monarthritis, aseptic osteolysis, 
foreign body reactions 
Occupational dusts: silica, 
asbestos, cotton, charcoal… 
Acute dust-induced lung injury  
Pneumoconiosis (silicosis, asbestosis, 
anthracosis) 
Dust-induced respiratory failure 
Lung fibrosis 
Tobacco smoke particulates Smoking-related COPD, emphysema Chronic respiratory distress 
Air pollutants Smog-related asthma, pneumonitis, 
COPD 
Acute respiratory distress 
CKD: chronic kidney disease, COPD: chronic obstructive pulmonary disease, SIRS: systemic 
inflammatory response syndrome. Adapted from Mulay, et. al.
4
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Deposition of β-sheets and amyloid fibrils can lead to nephrotic syndrome17,18. In contrast, 
during tumor lysis syndrome, uric acid is released from dying cells and MSU crystals deposit 
and obstruct the tubular lumen.14CKD is associated with genetic disorders, which often lead to 
the synthesis of different minerals such as brushite, CaCO3, CaOx, CaP, hydroxyapatite (HA), 
struvite uric acid and metabolites wherein the concentrations of such particles can reach 
supersaturation point leading to crystallization of crystalline particles.14 A rare genetic disease 
with deficiency of adenine phosphoribosyl transferase leads to 2,8-dihydroxyadenine (2,8-
DHA) nephropathy, where 2,8-DHA crystals form inside the renal tubules. An adenine-
enriched diet leads to 2,8-DHA  nephropathy in an animal model resulting in inflammation and 
kidney injury.19 Crystalline CKD refers to nephrocalcinosis.  
Type 3 crystalline nephropathy is associated with nephrolithiasis, ureterolithiasis or 
cystolithiasis. There are different factors involved in urolithiasis such as hereditary metabolic 
diseases related to higher production of cysteine, uric acid, or oxalate. Around 80% of all 
kidney stones are made of calcium stones.20 Calcium stones consist of 50% of CaOx, 5% of 
CaP and 45% of a mixture of CaOx and CaP.21,22 There are two types of CaOx crystals, CaOx 
monohydrate (COM, whewellite, CaC2O4·H2O) and CaOx dihydrate (COD, weddellite, 
CaC2O4·2H2O).23 Around 60% of the CaOx mixture account for both types.23 However, CaOx 
monohydrate is more stable than CaOx dehydrates and COM is also more observed in 
patients.22 Many factors are involved in CaOx stone formation, i.e., hypercystinuria, 
hypercalciuria, hyperoxaluria, hyperuricosuria, hypocitraturia, hypomagnesuria.24 Clinical 
manifestations such as gouty arthritis and uric acid kidney stones are associated with 
hyperuricemia.24 CaOx formation occurs mostly at a urinary pH of 5.0 to 6.5, while the urinary 
pH to form CaP stones is more than 7.24 The prevalence of urolithiasis in the US population is 
11%.25 Moreover, mutations in the genome that encode for mineral or metabolite transporters 
proteins develop supersaturation of minerals or metabolites in the urine.26 Another cause of 
urolithiasis is a diet rich in fructose or oxalate with low fluid intake, which can promote small 
crystals as well as stone formation.27,28 Stones are normally present in the renal pelvis, which 
can cause obstructing urinary outflow leading to kidney injury.25 Renal colic occurs as a result 
of sudden-onset pain in the flank or inguinal region.29 Oliguria can be present if both urinary 
tracts are affected.29 Elimination of the stone or stone passage decreases pressure and pain, and 
removal of such calculus can cause mucosal injury. However, renal colic is not related to long-
term urinary tract dysfunction except that chronic obstruction causes obstructive nephropathy 
and nephron loss. The diseases associated with Type 1, 2 and 3 can be found in table 2. 
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Table 2: Crystal or crystalline-induced kidney diseases 
Type Renal damage Disease Crystal (source of crystal-forming 
factor) 
Type 1 
(vascular)          
AKI   
CKD   
Cholesterol embolism 
atherosclerotic renal artery stenosis 
Cholesterol 
Cholesterol, apatite, CaP 
Type 2 
(tubular) 
 
AKI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CKD 
 
Diet-induced crystal nephropathy 
 
 
 
Drug-induced crystal nephropathy 
tumor lysis syndrome   
Drug-induced crystalluria 
Acute phosphate nephropathy 
 
Enteric crystal nephropathy 
 
 
Short bowel syndrome 
 
Myogen crystal nephropathy 
 
Bilirubin crystal nephropathy (bile cast 
nephropathy) 
 
Paraprotein-induced crystal nephropathy 
(light-chain cast nephropathy) 
 
CAKUT 
Genetic forms of RTA 
 
Genetic forms of hyperuricosuria 
Primary hyperoxaluria 
 
Cystinosis 
APRT deficiency 
 
 
Genetic diseases that cause nephrocalcinosis 
Dent disease, Lowe syndrome, idiopathic 
infantile 
Hypercalcemia and hypercalciuria 
Diet- or drug-induced crystal nephropathy 
 
Tophaceous gout 
 
 
 
 
Immunoglobulin-induced crystal 
nephropathies light-chain cast nephropathy, 
proximal tubulopathy with or without 
Fanconi syndrome, crystalglobulinemia, 
crystal-storing histiocytosis 
 
Chronic glomerular crystal nephropathies 
Cryoglobulinemia 
Crystalglobulinemia 
Cystinosis 
CaOx monohydrate (whewellite) 
CaOx monohydrate (whewellite) 
CaP,CaOx, and vitamin C 
 
 
Uric acid 
Drug crystals 
CaP 
 
CaOx monohydrate (whewellite) (bariatric 
surgery, IBD,celiac disease) 
 
CaOx dihydrate (weddellite) 
 
Myoglobin (rhabdomyolysis) 
 
Bilirubin crystal nephropathy (bile cast 
nephropathy) 
 
Monoclonal light chains 
 
 
 
 
Brushite, CaCO3, CaOx, CaP, 
hydroxyapatite, struvite 
Uric acid 
CaOx monohydrate (whewellite), CaOx 
dehydrate (weddellite) 
Cystine 
Adenine 
 
 
 
CaP, calcium pyrophosphate 
 
Uric acid (diets rich in sodium, fructose, 
sucrose) 
 
Uric acid (diets low in potassium, calcium, 
phytate, fluid administration as part of 
Mesoamerican nephropathy treatment) 
 
Monoclonal light chains 
 
 
 
 
 
 
 
Monoclonal and polyclonal IgG 
Monoclonal light chains 
Cystine 
Type 3 
(urolithiasis) 
 
Colic 
 
Monogenic crystal nephropathies (CAKUT) 
Genetic forms of RTA 
 
Primary hyperoxaluria 
 
Cystinosis 
 
 
Brushite, CaCO3, CaOx, CaP, 
hydroxyapatite, struvite 
CaOx monohydrate (whewellite), CaOx 
dehydrate (weddellite) 
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APRT deficiency 
Genetic forms of hyperuricosuria and 
hypercalciuria  
 
 
diet- or drug-induced crystal nephropathy 
 
Hyperuricosuric syndromes 
Drug crystalluria 
 
 
Enteric oxalosis 
Short bowel syndrome 
Cysteine 
Adenine 
Uric acid, CaOx, CaP 
 
 
CaOx, CaP (diets rich in oxalate, sodium, 
fructose, vitamin C, sucrose; diets low in 
potassium, calcium, phytate) 
Uric acid 
Drug crystals 
 
CaOx monohydrate (whewellite) 
CaOx dihydrate (weddellite) (bariatric 
surgery, IBD, celiac disease 
 
1.1.2. Source of crystals 
 
Crystallization can occur in different parts of the body.4,30 MSU crystals are the result of the 
crystallization of uric acid within joints, presenting as gouty arthritis.30 Kidney stone formation 
is due to the urinary supersaturation of calcium oxalate.31 On the other hand, crystalline 
particles can enter the body from the outside. Silicosis is a work-related lung disease caused by 
inhalation of crystalline silica particles.32 Silica particles accumulate within the alveolar sacs 
and ducts in the lungs, which lead to the formation of nodular lesions and fibrosis.33 Silica dust 
can be found in soil, mortar, plaster, and shingles. They are produced during cutting, breaking, 
crushing, drilling, and grinding. TiO2 particles are in a nanometer size of around 20 to 100 nm. 
They are widely used in cosmetic products like sunscreen, in which TiO2 blocks UV radiation 
according to the "EU Health scientific committee." Ultrafine TiO2 is also used in paints, 
plastics, cement, windows, tiles, and other products for UV absorption and photocatalytic 
sterilizing properties. Ultrafine TiO2 is considered as an occupational carcinogen, which has 
been shown to increase the risk for lung cancer in an animal model. TiO2 is also widely used 
in medicine, agriculture, building and food.34 The toxicity of TiO2 depends on the size, shape, 
aggregation and surface charge.35,36 It has been shown that TiO2 can affect cell cycle, 
constriction of nuclear membranes and apoptosis.37,38 TiO2 can be absorbed by inhalation, skin 
and injection and can be found in different organs such as lung, kidney, alimentary tract, liver, 
heart, spleen and cardiac muscle.36,39,34 
 
 
 
AKI: acute kidney injury, APRT: adenine phosphoribosyl transferase, CaCO3: calcium carbonate, CAKUT: 
congenital anomalies of the kidney and the urinary tract, CaOx: calcium oxalate, CaP: calcium phosphate, CKD: 
chronic kidney disease, IBD: inflammatory bowel disease, RTA: renal tubular acidosis. Adapted from Mulay, et. 
al.
14
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1.1.3. Crystalline particles induce inflammation 
 
The first evidence that macrophages were able to phagocytose particles such as silica, MSU 
crystal particles, and HA was first documented by electron microscopy about 40 years ago.40,41 
It has been shown, that crystals cannot be digested by macrophages but rather cause lysosomal 
damage, inflammation, and autophagy,42,4 whereas calculi, stones or implants are too big to be 
phagocytosed by the macrophages. As a consequence, they form a specific structure known as 
foreign-body giant cells, whereby two or more macrophages fuse together and try to engulf or 
cover such large particles.4 Recent studies showed that various crystals or crystalline particles 
such as MSU, CaOx, TiO2, asbestos, CPPD, HA, cholesterol, and alum crystals induce NLRP3 
inflammasome activation and secretion of IL‑1β and IL18 in macrophages .43,44,33,45,46,47 To 
activate the NLRP3 inflammasome complex, two signals are needed: The first signal (signal 
1) is mediated through damage-associated molecular patterns (DAMPs) or cytokines that 
increase NLRP3 and pro-IL‑1β expression level mediated via the nuclear factor-κB (NF-κB) 
pathway. The second signal (signal 2) including crystals or crystalline particles, triggers the 
assembly of the inflammasome complex including NLRP3, ASC, and pro-caspase-1. These 
processes lead to the activation of pro-caspase 1 and activate caspase 1, the process of pro- 
IL‑1β and pro-IL18 to mature IL‑1β and IL18. Then, mature IL‑1β or IL18 are secreted into 
the extracellular compartment and induce inflammation.48 The mechanisms of inflammasome 
activation upon crystals or crystalline particles uptake encompass lysosomal damage, 
phagolysosomal rupture and the release of cathepsin B 49,50,51, followed by cathepsin B 
activating NLRP3, an effect that can be blocked with the cathepsin B inhibitor CA-074-Me.52,53 
However, cathepsin B-deficient primary macrophages show no or less effect on inhibiting 
NLRP3 activation and IL‑1β production on stimulated macrophages or dendritic cells in 
response to hemozoin, MSU, alum, and silica.54 This observation suggests that CA-074-Me 
can block other cathepsin proteins. Indeed, Orlowski, et al. showed that multiple cathepsins 
can activate NLRP3 and induce IL‑1β or IL18 release.55 A role for cathepsin on NLRP3 
inflammasome formation and activation as well as potassium efflux has been demonstrated in 
response to various crystal or crystalline particles. Muñoz-Planillo, et al. showed that 
macrophages exposed to CPPD and silica particles cause potassium efflux leading to NLRP3 
and inflammasome activation.56 Interestingly, activated caspase 1 can cleave gasdermin-D 
(GSDMD) and produce N-terminal GSDMD leading to the activation of the regulated necrosis 
cell death pathway known as pyroptosis, followed by the release of DAMPs into the 
extracellular compartment. IL‑1β/IL18 and pyroptosis contribute to the auto-amplification loop 
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of necroinflammation that mediates renal injury.49 Interestingly, crystalline particles can induce 
inflammation independent of phagocytosis, whereby crystals interact with the cell membrane 
without internalization and sufficiently induce NLRP3-dependent ion influx.33 
1.1.4. Crystalline particles induce cell death 
 
Several studies suggested that crystals induce apoptosis, a predominant form of cell death 
dependent on the activity of caspases.57,58,59 For example, IYER, et al. showed that silica 
induces apoptosis in human macrophages. In this study, the authors used only cytosolic histone-
bound DNA fragments as a cell death ELISA assays to show apoptosis and Z-Val-Ala-Asp- 
fluoromethyl ketone have been used as caspase 1 inhibitor.60 Meanwhile, caspase 1 is well-
known to induce pyroptosis upon inflammasome activation in macrophages. In another study, 
Refsnes M, et al. showed by using the fluorescence activated cell sorting (FACS) that mineral 
particles of different physical-chemical properties induce apoptosis in alveolar macrophages.57 
Our group showed for the first time that crystals or crystalline particles can activate the 
necroptosis pathway directly via RIPK1, RIPK3, and MLKL proteins.16 In this study, Mulay 
SR, et al. reported that CaOx, MSU, CPPD, and cystine have cytotoxic effects on mouse and 
human tubular epithelial cells as well as primary human synovial fibroblasts. Cells exposed to 
crystal particles induce phosphorylation of Ripk1, then phosphorylated Ripk1 triggers Ripk3 
phosphorylation with subsequent phosphorylated Ripk3 induced Mlkl phosphorylation and 
oligomerization. As a result, phosphorylated Mlkl translocates into the plasma membrane and 
cell rupture occurs. During this process, cytokines and chemokines are released that trigger 
inflammation in the organ. Interestingly, blocking the main proteins involved in the necroptosis 
pathway such as RIPK1, RIPK3, and MLKL with chemicals or using a genetic approach 
showed a protective effect on renal epithelial tubular cells and fibroblasts. Surprisingly, 
ZVAD-FMK alone, a pan-caspase inhibitor, had no protective effect on cells exposed to crystal 
particles. These results suggest that caspase-dependent pathways such as apoptosis or 
pyroptosis are not involved in crystal or crystalline particles cytotoxicity. Interestingly, mice 
deficient in the two core proteins of the necroptosis pathway Ripk3 or Mlkl developed less 
severe oxalate crystal-induced acute kidney injury compared to wild-type mice.16 In addition, 
human progenitor cells exposed to CaOx, MSU, CPPD, and cystine showed protective effect 
when RIPK1 or MLKL were inhibited using chemical inhibitor. This discovery shed new 
insight into the cytotoxic effects of crystal particles. Interestingly, tumor necrosis factor 
receptor 1 (Tnfr1) andTnfr2-deficient mice showed less injury in oxalate-induced kidney 
injury. Yet, the exact mechanism of how crystals bind to TNFR receptors or how crystals 
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activate TNFR receptors is still uncertain. A further study from our group demonstrated that 
necroptosis is the predominant cell death pathway in neutrophils exposed to crystal or 
crystalline particles. Desai J, et al. reported that RIPK3 and MLKL are needed in neutrophils 
stimulated with MSU, CaOx, silica, CaP crystal to release extracellular trap-like chromatin.61 
Neutrophil necroptosis was limited when RIPK1, RIPK3, and MLKL were blocked using 
chemical inhibitors. The in-vivo model of gout-like tophus formation that involves suicidal 
NETosis similar to gouty arthritis showed less tophus formation in Ripk3-and Mlkl-deficient 
mice.61,62 These results demonstrate that RIPK3 and MLKL are required for neutrophil cell 
death exposed to crystal or crystalline particles. However, both studies showed partial effects 
on crystal or crystalline particles cytotoxicity when necroptosis was blocked. These data 
suggest the involvement of other cell death pathways. 
Another critical aspect of crystal or crystalline particles-related diseases is the origin of crystal 
particles. As mentioned earlier, crystals or crystalline particles can form inside the body, such 
as CaOx crystal particles or enter the body from the outside, such as silica particles. For a better 
understanding of the molecular mechanisms in each cell death pathway, the details of each 
pathway are presented. 
1.2. Cell death pathways 
 
Cell death refers to a highly complex biological event, which is crucial in many processes such 
as infection, immune system development, tissue homeostasis, and removal of damaged 
cells.63,64 Traditionally, it was believed that cell death is divided into two main pathways, 
apoptosis known as programmed cell death, characterized by Kerr, et al. for the first time in 
1972 65 and necrosis previously known as un-programmed cell death.66 These two pathways 
differ by morphological changes. For example, apoptosis defined by shrinking of the cells, 
plasma membrane blebbing, condensation of the nucleus, and internucleosomal DNA 
fragmentation. The dead cells are packaged into an apoptotic body, which is engulfed and 
removed by phagocytes.67 Apoptosis is considered as non-immunogenic cell death due to the 
formation of apoptotic bodies, which do not release DAMPs as danger signals. The initiation 
of apoptosis can be divided into an intrinsic or an extrinsic pathway. Both pathways involve 
caspase enzymes to execute cell death. However, necrotic cell death characterized by plasma 
membrane loss, random DNA degradation and DAMPs release, which results in strong immune 
responses.68 Necrotic cell death is considered as an accidental event without including any 
molecular mechanism opposite to apoptosis. However, for the first time, Laster, et al. in 1988 
reported that tumor necrosis factor (TNF) can induce necrotic and apoptotic cell death.69 Later 
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on, between 1992 to 1998, more studies reported that necrotic cell death can be regulated. For 
example, mitochondrial ROS requires a cytotoxic response to TNF in L929 (murine fibroblast) 
cells.70 However, the mechanism of regulated necrosis were not well understood until 2000, 
when Holler, et al. reported a non-apoptotic cell death pathway in primary T cells. This 
pathway is independent of caspase enzyme activity but dependents on the FADD (FAS-
associated protein with a death domain) protein, known as RIPK1, and its enzyme activity.71 
In the following years, several studies referring to necrosis as programed cell death. In 2005, 
Degterev, et al. discovered a small chemical molecule known as necrostatin-1 (Nec1), which 
could potentially block programmed cell death independent of caspases activity in different 
cell types. They named this form necroptosis as a non-apoptotic type of programmed cell 
death.72 Nec1 can block RIP kinases protein, which is a crucial element in the necroptosis 
pathway.73 The programmed cell death topic became highly interesting and kept on growing. 
Meanwhile, many different non-apoptotic pathways were defined, including necroptosis, 
ferroptosis, pyroptosis, MPT, and parthanatos (Figure 1).  
 
 
 
Figure1: Apoptosis and pyroptosis pathways are dependent on caspases activity. Apoptosis cell 
death does not lead to inflammation (non-immunogenic), while pyroptosis is highly immunogenic 
due to the release of IL‑1β and IL18. Necroptosis, MPT, ferroptosis, and parthanatos are 
independent of caspases activity.  IL-1β: interleukin 1 beta, IL18: interleukin 18, MPT: 
mitochondrial membrane permeability transition. 
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1.2.1. Apoptosis 
 
As mentioned earlier, the apoptosis pathway was the first described programmed cell death by 
Kerr, et al. in 1972.65 The morphological hallmarks of apoptosis include cytoplasmic 
shrinkage, chromatin condensation, nuclear fragmentation as well as plasma membrane 
blebbing, which form the apoptotic body. Caspase proteins are involved in apoptosis activation 
and execution. Caspase proteins exist in their inactivated form, and upon induction, each 
caspase can cleave the other caspase protein at the identical sequence, which results in protease 
cascade activation. In humans, 11 caspases (1-11 and 14) have been identified.74,75 Caspases 
categorize in two groups based on their functions: 1. Initiator of apoptosis include caspases 2, 
8, 9, 10, and 12. Caspases 1, 5, and 11 initiate apoptosis through inflammation pathways. 2. 
Effectors of apoptosis include caspases 3, 6, and 7. Both intrinsic and extrinsic pathways can 
induce caspase proteins depending on different signals. DNA damage, ROS production, 
microtubular changes, endoplasmic reticulum stress and mitotic defects trigger intrinsic 
pathway.76,77 Mitochondrial outer membrane potential (MOMP) controls the intrinsic pathway 
of apoptosis.78,79 The BCL-2 family controls MOMP. Upon activation of MOMP, different 
proteins such as cytochrome c are released into the cytoplasm and activate caspase proteins. 
Cytochrome c induces caspase 3 activation through the apoptosome complex to contain 
cytochrome c/Apaf-1/caspase-9 80. Cytochrome c directly binds to the C-terminal of Apaf-1 
protein and facilitates the association of dATP with Apaf-1 which results in exposing of its N-
terminal CARD, which can recruit and activate caspase 9 through CARD-CARD interaction.81 
Activated caspase 9 induces caspase 3 as an effector mediator in apoptosis cell death.82 
However, the extrinsic apoptosis signalling pathway involves the transmembrane receptor 
known as death receptor.83 Death receptors are involved in the TNF receptor gene 
superfamily.83 TNF receptor family members have similar cysteine-rich extracellular domains 
as well as cytoplasmic domain around 80 amino acids known as the death domain.84 The death 
domain plays a crucial role in transferring signals from the cell surface into the intracellular 
pathways. Some different receptors and ligands have been identified, such as TNF-α/TNFR1, 
Apo3L/DR3, Apo2L/DR4, FasL/FasR and Apo2L/DR5.84,85,86,87,88 Upon binding of the TNF 
ligand to TNFR1, adapter proteins such as  Fas-associated death domain (FADD) and TNF 
receptor-associated death domain (TRADD) are recruited.89 Pro-caspases 8 and 10 can bind to 
these adaptor proteins, which results in the formation of the death-inducing signaling complex 
(DISC), complex I and complex II.90,91 FAS ligand and TRAILR receptors can stabilize the 
receptor homotrimers to trigger a configurational change on intracellular tails that facilitate the 
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death domain (DD)-dependent association of the adapter FADD.92,93 Then, FADD activates 
DISK assembly by promoting the death effector domain-dependent recruitment of CASP8 or 
CASP10 and c-FLIP as multiple isoforms. The extrinsic apoptosis execution can be divided 
into two different pathways, type I cells (for example, thymocytes and mature lymphocytes) 
dependent on CASP8 proteolytic, which maturate executioner CASP3 and CASP7. Upon TNF-
α stimulation, RIPK1 recruits to complex I, which is independent of TRADD, then RIPK1 is 
polyubiquitinated with the help of c-IAP1, c-IAP2, and LUBAC.94,95 These processes can drive 
inflammation and cell survival by recruitment of TGF-beta activated kinase 1 MAP3K7-
binding protein 2 (TAB2), TAB3, and mitogen-activated protein kinase kinase kinase 7 
(MAP3K7). In addition, this event can promote mitogen-activated protein kinase (MAPK) or 
IkB kinase that depend on nuclear factor kappa light chain enhancer of activated B cells (NF-
κB) activation,96,97 and promote survival process. Nonetheless, apoptosis is considered as non-
immunogenic pathway and differs from regulated-necrosis. 
1.2.2. Necroptosis      
 
The necroptosis pathway is a type of regulated necrosis that is distinct from apoptosis. 
Activation of necroptosis leads to plasma membrane rupture and induces inflammation 98, 
which can be triggered by inducing death receptors, including FAS, TNFR1, TNFR2 99,73, TNF-
related apoptosis-inducing ligand receptor 1/2,71 as well as toll-like receptor (TLR)3 and 
TLR4.100,101 At the molecular level, RIPK1, RIPK3, and MLKL proteins drive necroptosis 
(Figure 2).102,103 TNFR1 activation leads to induction of NF-kB, which promotes either cell 
survival or apoptosis or necroptosis depending on the microenvironment, various signals as 
well as cell types. Apoptosis and necroptosis are highly interlinked on the molecular level 
(Figure 2A).63 Interestingly, some of the apoptosis inducer can initiate the necroptosis pathway, 
typically when casp8 is blocked (Figure 2C). For example, TNF ligand can lead to both 
apoptosis and necroptosis depending on casp8 activity (Figure 2B-D).63  On the other hand, 
casp8 can cleave Ripk1 and therefore limiting necroptosis (Figure 2B)104. Other stimuli such 
as TLR2, 3, 4, 5 and 9, DNA damage and IFN, mitochondrial antiviral signalling protein, 
retinoic acid-induced gene 1, anti-cancer drugs such as obatoclax, shikonin, and smac mimetic, 
vaccinia infection, can induce necroptosis through the activation of death receptor-like TNFR, 
FAS, and TRAILR.72,71,105 Interestingly, it was reported that ROS production can induce 
necroptosis through activation of RIPK1 phosphorylation.106 On the other hand, MLKL 
activation leads to NLRP3 induction through potassium efflux, recruited ASC, and pro-caspase 
1, which results in the formation of the NLRP3 inflammasome and IL-1β release as well as 
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activation of the pyroptosis pathway.107 This event occurs in a necroinflammation loop and 
release of pro-inflammatory cytokines, DAMPs, and histones, which then trigger 
necroptosis.108 Many studies showed that RIPK1 and RIPK3 play a crucial role in tissue 
injury.109,110 For example, inhibition of Ripk1 with Nec1 can limit the area of infarction in 
ischaemia-reperfusion injury (IRI) in the brain.72 In line with previous studies, necroptosis 
inhibition leads to reduced cardiac as well as kidney IRI.111,112 In addition, Ripk3-deficient mice 
with transplanted allogeneic kidneys showed less necrosis area and prolong survival in the 
transplant recipients of the wild-type group.113 Recent studies showed that crystalline particles 
such as CaOx, MSU, and silica can induce necroptosis and lead to organ injury.16,61 Crystal 
particles can activate RIPK3 and MLKL proteins resulting in renal tubular cell injury. Ripk3-
and-Mlkl-deficient mice presented with less injury in oxalate crystal-induced AKI.25 However, 
the exact mechanism of activating necroptosis remains unclear. Accumulating evidence 
suggest that necroptosis can be used as therapy target in kidney related-diseases. Necroptosis 
is implicated in several diseases that involve organ injury and inflammation processes such as 
kidney injury, sepsis, inflammatory bowel disease, neurodegenerative diseases, and 
atherosclerosis.108,114 However, other regulated-necrosis pathways including mitochondrial 
membrane permeability transition-related necrosis (MPT-RN), pyroptosis, and ferroptosis, can 
also lead to tissue injury and organ injury. However, they induce tissue injury via different 
molecular mechanisms.  
1.1.1. Mitochondrial membrane permeability transition-related necrosis 
 
MPT-RN is a form of cell death associated with permeability changes of the inner 
mitochondrial membrane, which was first described in 1979.115 It has been shown that MPT 
can be induced by a high concentration of mitochondrial Ca2+ and oxidative stress, resulting 
in necrotic morphology.115,116,117 Permeability transition pore complex can form between the 
inner mitochondrial membrane and outer mitochondrial membrane during activation of MPT. 
The molecular mechanism of MPT relies on a protein known as peptidylprolyl isomerase F 
(PPIF) (cyclophilin D, CYPD), which has been validated by genetic tools.118 In addition, 
blockade of PPIF protein with chemical inhibitors such as cyclosporin A (CsA)119, sanglifehrin 
A 120, and JW47121 prevent MPT-driven necrosis. However, a clinical study in 2015 (the 
CIRCUS trial) using CsA as intervention showed no cardioprotective effects on patients before 
percutaneous coronary intervention (PCI) with acute myocardial infarction.122 Although, a 
previous study in 2008 showed some protective effect on using CsA.123 
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Figure 2. The overview of the necroptosis pathway. A: Upon TNF ligand-TNFR interaction, 
complex I, including TRADD, TRAF2/5, cIAPs, and RIPK1, is formed. cIAP proteins promote 
RIPK1 polyubiquitinating, and the complex I leads to activation of the NFKb pathway through 
TAK1 complex. B: Deubiquitinating enzymes like CYLD can remove the Lys63 chain from RIPK1, 
which recruit TRADD, caspase 8 and FADD and form complex IIa. These two proteins can cleave 
RIPK1 and RIPK3 resulting in the activation of apoptosis independent of RIPK1. C: Inactivation 
of caspase 8 can lead to RIPK1 phosphorylation, which induces RIPK3 phosphorylation; thus 
MLKL gets phosphorylated. This complex named necrosome and lead to oligomerization of MLKL. 
MLKL oligomers translocate into the plasma membrane and activation of necroptosis pathway 
occurs. D: If cIAP proteins get inactivated caspase 8, RIPK1, FADD form a complex IIb, which 
induces the apoptosis pathway-dependent on RIPK1. TNF: tumor necrosis factor, TNFR: tumor 
necrosis factor receptor,  TRADD: tumor necrosis factor receptor type 1-associated DEATH 
domain, TRAF2/5: TNF receptor-associated factor 2/5, cIAP: cellular inhibitor of apoptosis 
protein, RIPK1: receptor-interacting serine/threonine-protein kinase 1, RIPK3: receptor-
interacting serine/threonine-protein kinase 3, NFkB: nuclear factor 'kappa-light-chain-enhancer' of 
activated B-cells, TAK1: transforming growth factor beta-activated kinase 1, CYLD: CYLD lysine 
63 deubiquitinase, MLKL: mixed lineage kinase domain like pseudokinase. 
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Such contradictory results could be due to using different methods to measure infarct size and 
specific formulation of CsA, which was used in the CIRCUS trial.124 Ppif-deficient mice were 
protected from ischemic or toxic acute kidney injury.111,125 Vaseva AV, et al. showed that P53 
interacts with Ppif and contributes to mitochondrial pore opening, which leads to cell necrosis 
in brain injury.126 However, the exact mechanism is unclear.127 Another protein involved in the 
permeability transition pore complex is the voltage-dependent anion channel (VDAC). VDAC 
protein plays an essential role in controlling the trafficking of metabolites such as ATP, ADP, 
and respiratory substrates.128 A recent study identified ANT family genes including Ant1, Ant2, 
and Ant4 to play an important role in MPT-driven cell death. Surprisingly, the deletion of Ant 
and Ppif resulted in complete inhibition of MPTP.129 These results support the “multi-pore 
model,” in which there are two distinct molecular components involved.129 However, these 
data need to be validated and confirmed in animal disease models. A relevance in human 
diseases is still unclear. Interestingly, the MPT pathway seems to be involved in neutrophil 
activation and to induce NETosis.130 The inhibition of PPIF by using CsA leads to less ROS 
production and less NETosis.130 However, these data need to be confirmed by genetic tools. 
Interestingly, hyperactivation by poly (ADP-ribose) polymerase 1 (PARP1) can result in 
MOMP and mitochondrial damage.131,132 Although, PARP1 activation is associated with 
parthanatos, a non-apoptotic cell death pathway. The parthanatos pathway is associated with 
the DNA damage response machinery and it can be induced in response to oxidative stress, 
hypoxia, hypoglycemia, inflammatory condition, and alkylating DNA damage.131,133 However, 
the role of PPIF protein as the main regulator of mitochondrial function has not been described 
in PARP1 dependent-cell death.  
1.1.2. Pyroptosis 
 
Pyroptosis is a caspase-dependent form of regulated necrosis.  Cookson and Brennan defined 
a pro-inflammatory regulated cell death based on caspase 1 activity and first used the term 
pyroptosis.134 It was thought that pyroptosis is specific to macrophages or monocytes due to 
activation of caspase 1.135,136 A recent study demonstrated that pyroptosis can be induced by 
caspase 3 137 and in different cell types such as T lymphocytes138, neurons139, and tubular 
epithelial cells.140,141 The molecular mechanism of pyroptosis relies on the activation of caspase 
proteins such as caspase 1, caspase 3, and caspase 11 (murine), caspase 4 (human), and caspase 
5, which depends on the stimulus.142,143 Pyroptosis leads to the secretion of IL-1β and IL18, 
induce robust pro-inflammatory markers, and, therefore, is considered as high immunogenic 
cell death pathway.144,145 Different studies showed that pyroptosis could be triggered via 
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cytosolic lipopolysaccharides (LPS) as gram-negative bacterial infection through the activation 
of caspase 11 but independent of caspase 1.146,147,148,149 The execution of pyroptosis is 
associated with proteolytic cleavage of GSDMD protein.150,151 Gsdmd-deficient macrophages 
showed a protective effect upon LPS stimulation. In addition, Gsdmd-deficient mice have 
survived a lethal dose of LPS.150,151 It has been shown that GSDMD is auto-inhibited through 
binding of the C-terminal repressor domain to the N-terminal pore-forming domain. Upon 
activation, caspases can cleave the inter-domain and release GSDMD-N, which translocate to 
the plasma membrane and bind to phosphoinositides.152,153 This interaction results in GSDMD-
N oligomerization, pore formation, and rapid plasma membrane permeabilization.152,154 
Therefore, the pyroptosis dependent-cell death pathway leads to the release of inflammatory 
mediators, and inflammation. 
1.1.3. Ferroptosis  
 
Ferroptosis is a form of regulated necrosis cell death, which depends on lipid peroxidation 
followed by ROS generation and iron.155,156 Yagoda N, et al. have identified a chemical 
compound known as erastin that can induce a form of cell death in resistant RAS-transformed 
cancer cells.157 Ferroptosis occurs independent of caspase activity, necrosome formation, PPIF 
as well as autophagy.158 Morphological characterization of ferroptosis is associated with 
necrotic and mitochondrial alteration mainly related to an electron-dense ultrastructure, a 
decrease in cristae and outer membrane rupture.117 Ferroptosis is an immunogenic cell death 
pathway due to the release of DAMPs.159 The molecular mechanism of ferroptosis relies on a 
protein known as glutathione peroxidase 4 (GPX4). GPX4 is the main regulator of the 
ferroptosis pathway by inhibiting lipid peroxidation through promoting glutathione (GSH)-
dependent reduction of lipid hydroperoxides to lipid alcohols.160,161 In line with these findings, 
erastin induces ferroptosis by indirectly preventing cystine/glutamate antiporter system Xc
−, 
that results in decreased intracellular cysteine and GSH.158,161 Therefore, blocking GSH with 
L-buthionine sulfoximine, the glutamate-cysteine ligase complex is able to trigger ferroptosis 
-regulated cell death.160 The Food and Drug Administration (FDA)-approved tyrosine kinase 
inhibitor sorafenib can persuade ferroptosis through blocking GSH upon system Xc
− 
inhibition.162,163 Recently, altretamine has been identified using genome-wide screening as 
potential inhibitor of GPX4.164 A large body of evidence suggest that GPX4 pro-survival 
activity participates in development as well as homeostatic tissue maintenance. Gpx4-deficient 
mice showed embryonic lethality.165,166 Friedmann Angeli JP, et al. demonstrate that inducible 
Gpx4-deficient mice develop acute renal failure.160 In addition, GPX4 is essential in hepatic 
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injury167, neurodegeneration165, as well as toxic renal injury168, and Parkinson disease.169 
However, the details of how GPX4 protein contributes to cell death and organ injury is not very 
well understood.  
 
 
As mentioned earlier, necroptosis is involved in metabolic crystal particle-induced kidney 
injury.25 Many studies have reported that occupational work-related diseases are associated 
with crystal particles, including silica, nanomaterials, and crystal-related bone remodeling, 
which can deposit within different parts of the body. However, there are no data available on 
whether environmental crystals can share the same mechanisms of cell death as metabolic 
crystal particles or not. In addition, whether crystalline particles can activate another form of 
regulated necrosis or not is currently not known. Therefore, in this thesis, we intend to answer 
these questions. 
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2. Hypotheses 
 
Crystal particles result in clinical complications once they deposit within the human body. 
Various crystal particles lead to tissue and organ injury, for example, CaOx is involved in 
nephrolithiasis, oxalate nephropathy, and acute kidney injury, cholesterol can lead to 
cholesterol embolism and atherosclerosis, MSU is involved in gout. Occupational and air 
pollution-related diseases like silicosis, asbestosis, pneumoconiosis, smoking-related COPD, 
and chronic respiratory distress are considered as serious global health problem leading to death 
of millions of people. There are no effective drugs available to limit the cytotoxic effects of 
crystal particles directly. We first need to better understand the molecular mechanisms of 
crystal- or crystalline particle-induced tissue injury. It is still not clear whether environmental 
particles can activate necroptosis and whether other forms of cell death are involved in 
crystalline particle-induced tissue and organ injuries.  
 
Therefore, we hypothesized that: 
 
1. Acute tissue injury leading to progressive organ damage is associated with 
increased expression of necroptosis-related genes  
 
2. Environmental and metabolic crystals, regardless of their shape and size, induce 
necroptosis in human and mouse renal tubular primary and immortalize cells. 
 
3. Crystalline particles induce MPT as an alternative cell death pathway to drive 
organ injury. 
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3. Materials and Methods 
 
3.1. Instruments and Chemicals 
 
3.1.1. Instruments 
 
Balance:  
Analytic Balance, BP 110 S Sartorius, Göttingen, Germany 
Mettler PJ 3000 Mettler-Toledo, Greifensee, Switzerland 
Cell Incubator:  
Type B5060 EC-CO2 Heraeus Sepatech, Munich, Germany 
Centrifuges:  
Heraeus, Biofuge primo Kendro Laboratory Products GmbH, Hanau, Germany 
Heraeus, Sepatech Biofuge A Heraeus Sepatech, Munich, Germany 
ELISA-Reader:  
Tecan, GENios Plus Tecan, Crailsheim, Germany 
Fluorescence Microscopes:  
Leica DMi8 Leica Microsystems, Cambridge, UK 
Olympus BX50 
Zeiss Libra 120 TEM   
Electron Microscope: 
JEOL EXII 1200       
FEG-SEM Quanta 250  
Olympus Microscopy, Hamburg, Germany 
Zeiss, Germany 
 
Jeol, Tokyo, Japan 
Thermo Fisher Scientific, FEI, Hillsboro, OR 
Spectrophotometer:  
Beckman DU® 530 Beckman Coulter, Fullerton, CA, USA 
TaqMan Sequence Detection 
System: 
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qRT-PCR syber green  LC-480                                                           ROCHE, Mannheim, Germany 
Transfection device: 
Neon  
Other Equipments: 
 
Invitrogen, Germany 
Nanodrop PEQLAB Biotechnology GMBH, Erlangen, Germany 
Cryostat RM2155 Leica Microsystems, Bensheim, Germany 
Cryostat CM 3000 Leica Microsystems, Bensheim, Germany 
Microtome HM 340E Microm, Heidelberg, Germany 
pH meter WTW WTW GmbH, Weilheim, Germany 
Thermomixer 5436 Eppendorf, Hamburg, Germany 
Vortex Genie 2™ Bender & Hobein AG, Zürich, Switzerland 
Water bath HI 1210 
XtremeCT scanner 
Leica Microsystems, Bensheim, Germany 
SCANCOMedical AG, Brüttisellen, Switzerland 
 
3.1.2. Chemical and Reagents 
 
RNeasy mini kit 
RNA isolation kit 
Qiagen GmbH, Hilden, Germany 
Ambion (Ambion, CA, USA) 
RT-PCR primers Metabion, Munich, Germany 
ROS assay: DCFDA dye 
TMRE 
Epoxy glue 
Lysotracker 
Calcein 
Propidium iodide 
Acridine Orange 
Sigma lifesciences, Germany 
Invitrogen, Carlsbad, CA 
Model 2400; CircuitWorks, Kennesaw, GA 
Abcam, Cambridge, UK 
Invitrogen, Carlsbad,CA 
Invitrogen, Carlsbad, CA 
Sigma lifesciences, Germany 
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LDH cytotoxicity assay 
MTT viability assay 
Durcupan ACM 
Silver paint 
Quorum Q150TS 
GenMute  
TNF-α  
Superscript reverse transcriptase II 
Cell culture: 
Roche, Germany 
Sigma-Aldrich, Steinheim, Germany 
Merck Sigma-Aldrich, Darmstadt, Germany 
Agar Scientific Ltd, Stansted, UK 
Quorum Technologies, Laughton, UK 
SignaGen Laboratories, US 
Immunotools, Germany 
Invitrogen, Karlsruhe, Germany 
DMEM-medium Biochrom KG, Berlin, Germany 
RPMI-1640 medium GIBCO/Invitrogen, Paisley, Scotland, UK 
FCS Biochrom KG, Berlin, Germany 
Dulbecco’s PBS (1×) PAN Laboratories GmbH, Cölbe, Germany 
Trypsine/EDTA (1×) PAN Laboratories GmbH, Cölbe, Germany 
Glutamine  PAN Laboratories GmbH, Cölbe, Germany 
Penicillin/Streptomycin (100×) 
Prostaglandin E1 
EGF 
I-T-SS 
l-thyroxine 
Hydrocortisone 
PAN Laboratories GmbH, Cölbe, Germany 
Calbiochem, Darmstadt, Germany 
Sigma-Aldrich, Munich, Germany 
Sigma-Aldrich, Munich, Germany 
Sigma-Aldrich, Munich, Germany 
Sigma-Aldrich, Munich, Germany 
Inhibitors  
Nec-1s Enzo Life Sciences, Lörrach, Germany 
Necrosulfanamide Millipore, Schwalbach, Germany 
Pan caspase inhibitor zVAD 
CsA  
Enzo Life Sciences, Lörrach, Germany 
Sigma-Aldrich, Munich, Germany 
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APDC 
Cytochalasin D 
CA074Me 
Sigma-Aldrich, Munich, Germany 
Calbiochem, Darmstadt, Germany 
Calbiochem, Darmstadt, Germany 
Antibodies:  
Ripk3 Abcam, Cambridge, United Kingdom 
Mlkl Abcam, Cambridge, United Kingdom 
SMA Abcam, Cambridge, United Kingdom 
Collagen1α1 DAKO, Hamburg, Germany  
Elisa and assay Kits:  
Creatinine FS DiaSys Diagnostic System, GmBH, Holzheim, 
Germany 
Chemicals:  
Acetone Merck, Darmstadt, Germany 
Bovines Serum Albumin Roche Diagnostics, Mannheim, Germany 
DEPC Fluka, Buchs, Switzerland 
DMSO Merck, Darmstadt, Germany 
EDTA Calbiochem, SanDiego, USA 
Ethanol Merck, Darmstadt, Germany 
Formalin Merck, Darmstadt, Germany 
Hydroxyethyl cellulose Sigma-Aldrich, Steinheim, Germany 
HCl (5N) Merck, Darmstadt, Germany 
Isopropanol Merck, Darmstadt, Germany 
Calcium chloride Merck, Darmstadt, Germany 
Calcium dihydrogenphosphate Merck, Darmstadt, Germany 
Calcium hydroxide Merck, Darmstadt, Germany 
Beta mercaptoethanol Roth, Karlsruhe, Germany 
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Sodium acetate Merck, Darmstadt, Germany 
Sodium chloride Merck, Darmstadt, Germany 
Sodium citrate Merck, Darmstadt, Germany 
Sodium dihydrogenphosphate Merck, Darmstadt, Germany 
Penicillin Sigma, Deisenhofen, Germany 
Roti-Aqua-Phenol Carl Roth GmbH, Karlsruhe, Germany 
Streptomycin Sigma, Deisenhofen, Germany 
Crystals:  
Calcium oxalate Alfa aesar, Karlsruhe, Germany 
MSU 
Calcium phsphate 
Invivogen, Toulouse, France  
Chem Cruz 
Calcium pyrophosphate dihydrate Invivogen 
Cholesterol Invivogen, Toulouse, France 
Silica Alfa aesar, Karlsruhe, Germany 
TiO2 Io-li-Tec, Germany 
Miscellaneous:  
Preseparation Filters Miltenyl Biotec, Bergish Gladbach, Germany 
Needles BD Drogheda, Ireland 
Pipette’s tip 1-1000μL Eppendorf, Hamburg, Germany 
Syringes Becton Dickinson GmbH, Heidelberg, Germany 
Plastic histocasettes NeoLab, Heidelberg, Germany 
Tissue culture dishes Ø 100x20mm TPP, Trasadingen, Switzerland 
Tissue culture dishes Ø 150x20mm TPP, Trasadingen, Switzerland 
Tissue culture dishes Ø 35x10mm Becton Dickinson, Franklin Lakes, NJ, USA 
Tissue culture flasks 150 cm2 TPP, Trasadingen, Switzerland 
Tubes 15 and 50 mL TPP, Trasadingen, Switzerland 
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Tubes 1.5 and 2 mL TPP, Trasadingen, Switzerland  
 
 
All other reagents were of analytical grade and are commercially available from Invitrogen, 
SIGMA or ROCHE. 
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3.2. Experimental procedures 
3.2.1. Animals 
 
Ppif-deficient mice were obtained from Jackson laboratories (Bar Harbour, USA (Stock no: 
009071) and backcrossed to C57BL/6J mice. Mlkl-deficient mice were kindly provided by J. 
Murphy and W. Alexander, WEHI, and Australia.170 C57BL/6 male mice were purchased from 
Charles River. All mice were housed in groups of maximum five in filter-top cages with 
bedding and pulp, 22.2 °C and a 12 hours light/dark cycle, and had free access to food and 
water ad libitum. Cages, litter, nest lets, houses, food and water were sterilized by autoclaving 
at 121 °C and 1 bar pressure for 20 minutes. All experiments were done according to the EU 
directive (2010/63/EU) for animal welfare and German animal protection laws. Honarpisheh M, 
et al3, Mulay SR, Honarpisheh MM, et al.2 
3.2.2. Animal models 
 
Acute oxalate nephropathy: 
Ppif-deficient, Mlkl-deficient, and C57BL/6J mice were injected intraperitoneally with 100 
mg/kg sodium oxalate and received 3% sodium oxalate in drinking water. After 24 hours, the 
kidneys were harvested to evaluate the extend of kidney injury.47,16 For the therapeutic purpose, 
mice received a single injection of either CsA (2 mg/kg i.v., Sigma-Aldrich, Munich, Germany) 
or Nec1s (1.65 mg/kg i.p., Millipore, Darmstadt, Germany) or a combination of both prior to 
sodium oxalate injections. Honarpisheh M, et al3, Mulay SR, Honarpisheh MM, et al.2 
 
Chronic oxalate nephropathy: 
C57BL/6J mice were fed an oxalate-rich diet that was made by adding 50 μmol/g sodium 
oxalate to a calcium-free standard chow diet, and mice were sacrificed on day 7, 14 and 21.171 
Honarpisheh M, et al3  
 
Acute ischemia-reperfusion injury: 
Mice were killed after 24 hours of reperfusion of bilateral pedicle clamping group. The 
damaged kidneys were harvested for RNA isolation and histology analysis.  
Honarpisheh M, et al3 
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Cisplatin-induced nephropathy model: 
Mice received a single dose (intraperitoneal injection) of 20 mgkg−1 of cisplatin (Sigma-
Aldrich), and kidneys were collected after three days for RT-PCR and histology analysis.172 
Honarpisheh M, et al3 
3.2.3. Transmission Electron Microscopy (TEM) 
 
One drop of crystals suspended in PBS was transferred onto formvar-coated copper grids 
(Plano, Wetzlar, Germany). The extra liquid was removed after 30 seconds, and grids were 
allowed to dry. JEOL EXII 1200 TEM was used at 80 kV. KeenViewII (Olympus, Hamburg, 
Germany) camera was used to capture images and processed using iTEM software package 
(analySISFive, Olympus, Hamburg, Germany). For kidney tissue and cell processing, small 
pieces of kidney tissue were fixed in 3% PBS and cells fixed in 3% glutaraldehyde, followed 
by removal from the plate and centrifuged. 5% low-melting agarose was used to embed the cell 
pellets. Soerensen’s phosphate buffer (0.1 M) was used to wash tissue or gelatined blocks, 17% 
sucrose buffer and 1% OsO4 were used for post-fixation and dehydration by ethanol series 
with 30, 50, 70, 90 and 100% for 10 minutes each, which was repeated three times. Epon resin 
and propylene oxide were used to mix (1:1) dehydrated samples for 1 hour after incubation in 
propylene oxide for 30 minutes, than embedded in pure Epon. Polymerization was carried out 
at 90°C for 2 hours. An ultramicrotome with a diamond knife was used to cut thin sections of 
70-100 nm. The contrast was increased by staining with 0.5% uranylacetate and 1% lead citrate. 
Samples were visualized at an acceleration voltage of 60 kV using a Zeiss Leo 906 TEM.2 This 
method was carried out in collaboration with Bastian Popper (Biomedical Center, Core Facility 
Animal Models, Ludwig Maximilian University, Planegg Martinsried, Germany) and Peter 
Boor (Division of Nephrology, Institute of Pathology, Rheinisch-Westfälische Technische 
Hochschule University of Aachen, Germany). Mulay SR, Honarpisheh MM, et al.2  
3.2.4. Serial Block Face Scanning Electron Microscopy  
 
The enhanced staining protocol was used to stain fixed cells. Briefly, Durcupan ACM resin 
was used to embed the dehydrated and stained specimens, and mixed accordingly as per 
manufacturers’ protocol. Conductive epoxy glue was used to embed the tissue. The tissue was 
then trimmed to a pyramid, and mounted onto a pin. Silver paint was used to cover the sides of 
the pyramid and finally Quorum Q150TS was used to coat the whole assembly with platinum. 
The set of data from SB-EM were collected using FEG-SEM Quanta 250. Afterwards, the 
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images were processed by cutting the block faces into 30 nm and visualized with a resolution 
of 22 nm per pixel. An open-source software Microscopy Image Browser was used to process 
and segment all images. The final visualization of models was performed in Amira (Thermo 
Fisher Scientific, MA) 31296606.2 This method was carried out in collaboration with Ilya 
Belevich, and Eija Jokitalo (Electron Microscopy Unit, Institute of Biotechnology, University 
of Helsinki, Helsinki, Finland). Mulay SR, Honarpisheh MM, et al.2 
3.2.5. Small interfering RNA experiments 
 
Transient transfection was performed in L929 and HK2 cells with 120 nM of siRNA duplexes 
for PPIF (iBONi siRNA pool, Lot no.: 2017d0119, Riboxx, Radebeul, Germany), MLKL 
(Ambion, Foster City, CA) and scrambled siRNA (Ambion, Foster City, CA) using Neon 
electroporation device (Thermofisher, Germany). The parameters used for electroporation 
were as follow: Voltage: 1400v, with 20ms, pulses. Cells were exposed to 1 mg/ml CaOx 
crystals, 0.5 mg/ml silica, 0.5 mg/ml MSU, 0.5 mg/ml CPPD, 3 mg/ml cholesterol and 0.5 
mg/ml TiO2 for 48 hours post-transfection. Cell death was quantified by PI positivity and LDH 
assay 24 hours after exposure to crystals. Mulay SR, Honarpisheh MM, et al.2 
3.2.6. Assessment of renal injury 
 
The 2 µm kidney sections were stained with periodic acid-Schiff (PAS) reagent. Tubular 
damage was scored by assessing the percentage of necrotic tubules and tubular casts. CaOx 
crystals and crystal deposit in the kidney were determined using Pizzolato´s staining and 
assessed as (7, 8, and 45), No deposits = 0 points; crystals in papillary tip = 1 point; crystals in 
cortical medullary junction = 2 points; crystals in cortex = 3 points. The points were combined 
if crystals found in multiple areas. Plasma creatinine levels were analyzed using a commercial 
kit according to the manufacturer’s protocol. TUNEL kit was used to analyze dead cells. All 
assessments were performed in a blind manner. Mulay SR, Honarpisheh MM, et al.2 
3.2.7. Micro-computed tomography (µCT) 
 
For µCT scanning of PFA-fixed kidneys, a XtremeCT scanner was used. Scans were carried 
out at 20 µm voxel size with a 70 kV energy set as described previously.173 Kidney tissues were 
fixed in vertical (longitudinal) direction. The scan area was changed to include all organs, with 
a total of 490 slices and 45 minutes scanning. ImageJ software was used to analyze image 
density and 3D reconstruction. We performed this method in collaboration with Rostyslav 
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Bilyy (Department of Histology, Cytology, and Embryology, Danylo Halytsky Lviv National 
Medical University, Lviv, Ukraine). Mulay SR, Honarpisheh MM, et al.2 
3.3. Cell culture 
3.3.1. Cell freezing and thawing 
 
At earlier passages, cells were grown under normal culture conditions and frozen for future 
use. For freezing cells, cells were detached from the cell culture plates and centrifuged at 1000 
rpm for 3 minutes. The cell pellet was resuspended in 90 % FCS and 10 % DMSO by pipetting 
repeatedly up and down. 1 ml of the cells in freezing media were immediately poured into 
freezing vials (40C) and the cells slowly frozen at –200C for 1 hour and then at –800C overnight. 
All cells were transferred into liquid nitrogen on the next day. To thaw cells, a frozen vial was 
removed from liquid nitrogen and put into water bath at 370C. The cells were then put in 5 ml 
warm complete growth medium and centrifuged. The old medium was removed and fresh 
medium prior to transfer into a new culture plate. After 24 hours, the old medium was replaced 
with fresh medium.  
3.3.2. Cell culture studies 
 
Primary tubular epithelial cells (pTECs) were freshly isolated from kidney of Mlkl- (J. Murphy 
and W. Alexander, WEHI, Australia170), and Ppif-deficient mice (original strain 
Ppiftm1Jmol/J, Jackson Stock no: 009071) as well as from C57BL/6J (wildtype) mice. All cells 
were maintained in DMEM/F12 containing 10% fetal calf serum, 1% penicillin-streptomycin, 
125 ng/ml prostaglandin E1 , 25 ng/ml EGF, 1.8 μg/ml l-thyroxine, 3.38 ng/ml hydrocortisone 
and 2.5 mg/ml of insulin transferrin-sodium selenite supplement (I-T-SS). RPMI and 
DMEM/F12 were used to maintain human kidney cells (HK2) and L929 respectively, including 
fetal calf serum, 1% penicillin-streptomycin. Peter Nelson and Bruno Luckow, LMU Munich, 
Germany, kindly provided HK2 and L929 cells, respectively. All cells were cultured under 
standard conditions (incubator at 370 C, 5% CO2), followed by stimulation with various 
crystals such as CaOx (1 mg/ml, 1-2 µm size, silica (0.5 mg/ml, 1-5 µM size), MSU (1 mg/ml, 
25-125 nm size,), CPPD (0.5 mg/ml, 25-125 nm size), and TiO2 (0.5 mg/ml, 80 nm size). For 
treatment experiments, cells were pre-treated with MPT inhibitor CsA (0.5 and 1 μm), 
mitochondrial ROS inhibitor (2R, 4R)-4-aminopyrrolidine-2, 4-dicarboxylate (APDC) (100 
and 200 μM), cytochalasin D (CytD) (5 and 10 μM) as phagocytosis (actin-polymerization) 
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inhibitor, and cathepsin inhibitor CA074Me (10 and 20 μM) for 30 minutes prior to stimulation 
with crystals. The tetramethylrhodamine ethyl ester (TMRE), lysotracker (Abcam, Cambridge, 
UK), and the 2', 7’–dichlorofluorescin diacetate (DCFDA) dyes used to evaluate MOMP and 
ROS production. We used necrosulfonamide (NSA) (5 or 10 µM), dabrafenib (10 µM) or 
Nec1s (100 µM) as necroptosis inhibitor. Propidium iodide (PI) was used to quantify dead cells 
and calcein to evaluate live cells according to the manufacturer’s protocol. We used a Leica 
fluorescence microscope (Leica, Wetzlar, Germany) to detect positive fluorescence signals and 
ImageJ software (USA) to analyze and quantified them. We used the Lactate dehydrogenase 
(LDH) cell cytotoxicity assay (Roche, Mannheim, Germany) to evaluate cell death in the cell 
culture supernatants by detecting LDH that was released from dying cells. LDH assay was 
carried out according to the manufacturer’s protocol. Honarpisheh M, et al.1, Mulay SR, 
Honarpisheh MM, et al.2 
3.3.3. Cell death quantification using multi-parameter flow cytometry 
 
HK2 cells were stimulated with various crystals for 24 hours to induced cell death. Cell death 
was characterized by analyzing different parameters such as size, granularity, 
phosphatidylserine exposure, plasma membrane integrity, mitochondrial membrane potential, 
and DNA content174. Stimulated cells were harvested and incubated with 400 µl freshly 
prepared four-color staining solution , which contained 1.8 μg/ml AxA5-FITC, 100 ng/ml PI 
and 10 nM DiIC1 (5), and 1ng/ml Hoechst 33342 in Ringer’s solution for 30 minutes at room 
temperature. FACSCantoII flow cytometer (BD, Germany) was used to performed flow 
cytometry experiments. We used FlowJo software (USA) for analyzing the data. Cells were 
classified according to their position in the forward scatter (FSc; size) versus side scatter (SSc; 
granularity) dot plot and their staining analyzed as previously described 16. Briefly, primary 
necrosis was considered when cells expressed annexinV-FITC+, PI high, DilC1 (5) low, for 
secondary necrosis, cells expressed annexinV-FITC+, PIlow, DilC1 (5) low-int and for 
apoptosis cells were annexinV-FITC+, PI−, DilC1 (5) int-high. We recorded 100000 events to 
assure an equal number of cells. The gating strategy considered as sideward scatter vs. forward 
scatter and annexinV vs. PI staining. annexinV/PI staining was used to detect different cell 
populations, then characterized using the DilC1 (5) and Hoechst 33342 dyes. Honarpisheh M, 
et al.1 
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3.3.4. Histopathology 
 
The kidney tissues from mice were harvested, fixed in 4% formalin and embedded in paraffin. 
4 µm sections were stained for haematoxylin and eosin (H&E) and periodic acid–Schiff (PAS). 
The area of necrotic and tubular casts was evaluated by scoring tubular injury as mentioned 
above. The primary antibodies RIPK3, MLKL and SMA were used for immunostaining. Mulay 
SR, Honarpisheh MM, et al.2  
3.4. RNA analysis 
3.4.1. RNA isolation from murine solid organs and cells 
 
We preserved organs in RNA-later immediately after isolation and stored them at -20 °C until 
RNA isolation. RNA was isolated using a commercial kit. Briefly, 30 mg tissue was 
homogenized using a blade homogenizer for 30 seconds in lysis buffer (600 μl) containing β-
mercaptoethanol (10 μl/ml). The homogenized tissues were centrifuged at 6000 rpm for 5 
minutes and 350 µl of supernatants were transferred into fresh RNAas and DNAas free tubes. 
For cells, media was removed and the cells were harvested using 350 µl lysis buffer with β-
mercaptoethanol (10 μl/ml). We used 70% ethanol to mix either lysed cells or homogenized 
tissues, and loaded them on a RNA column before processing for RNA isolation as per 
manufacturer’s instruction. The purified RNAs were measured and stored at -80 0C. 
Honarpisheh M, et al.3 
3.4.2. Quantification and purity check of RNA samples 
 
The Nanodrop was used to quantify extracted RNA samples. The ratio of 260 nm and 280 nm 
was considered for RNA purity, which indicates contamination of proteins in the RNA samples. 
Samples with only a ratio of 1.8 or more were considered to have a good quality. Honarpisheh 
M, et al.3 
3.4.3. cDNA conversion 
 
The superscript reverse transcriptase II used for cDNA synthesis. Isolated RNAs were diluted 
in ultra-pure (RNAs and DNAs free) water to get a final concentration of 1 µg/15µl. We 
prepared the cDNA conversion reaction by mixing 9 μl 5x buffer , 1 μl 25 mM dNTP mixture, 
2 μl 0.1 M DTT, 1 μl 40U/ μl RNAsin , 0.5 μl  hexanucleotide, 1 μl of superscript or ultrapure 
water in the case of the control cDNA (RT minus). The diluted RNAs (1µg) were added to the 
13.9 µl master mix reaction and incubated at 420C for 1 hours and 30 minutes on a thermal 
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shaker. After incubation, converted cDNAs were stored at 200C until usage. We prepared 
cDNA samples (1:10) for real-time RT-PCR. In short, 10 µl SYBR green master mix, 0.6 μl 
forward primer and 0.6 μl of reverse primer, which are specific for the target gene, 0.16 µl Taq 
polymerase and 6.64 μl distilled water mixed with 2µl diluted cDNA samples. Honarpisheh M, 
et al.3 
3.4.4. Real-time PCR 
 
We used a SYBR green dye assay (SYBR Green I 96 protocol LC480 Roche) for RT-PCR. 
Light Cycler 480 was used to the quantification of real-time PCR. Amplification steps included 
the initiation phase (95 °C), annealing phase (60 °C) and amplification phase (72 °C) with a 
repetition of 45 times. The primer-blast online tool (NCBI) was used to designed specific 
primers for genes of interest. In addition, Primers-BLAST tool (NCBI) was used to check 
specificity of genes. The lengths of product PCR were between 80 to 130 pb. All primers were 
purchased from Metabion, Martinsried, Germany and are listed in table 3. Distilled water was 
used as negative control.  The efficiency was achieved using the Light Cycler 480 according 
to the standard curves describing the PCR efficiencies of the gene and the reference gene [ratio 
= E target Δ CP target (control-sample) / E ref Δ CP ref (control − sample)]. Crossing points 
(Cp) between 5 and 40 cycles were considered positive signals. Honarpisheh M, et al.3 The 
melting curves were analyzed for each sample to detect unspecific products and primer dimers. 
Honarpisheh M, et al.3 
3.5. Statistical analysis 
 
To check for normal distribution of the dataset, the Shapiro-Wilk Normal distribution test, the 
Levene homoscedasticity test and the Grubb outlier test were applied. Student’s t-test was only 
used for the comparison of two normally distributed datasets. Alternatively, in the case of two 
non-normally distributed datasets, the Wilcoxon-Mann-Whitney test was used. For more than 
two datasets, the normally distributed and homoscedastic datasets were evaluated by using one-
way analysis of variance (ANOVA) with Tukey’s post-test. In the case of heteroscedasticity, 
the post-hoc Games Howell test was used. In case of, two parameters with multiple groups, 
two-way ANOVA with Bonferroni’s comparison post-hoc test was carried out. All statistical 
analyses were performed using GraphPad Prism 7 (CA, USA). Unless otherwise indicated, data 
are presented as mean values ± standard error of the mean (SEM). Differences were considered 
significant if p<0.05; non-significant differences (ns) are indicated accordingly. Sample sizes 
were indicated in each corresponding figure legend. 
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Table: 3. Oligonucleotide primer sequences used in the study 
Gene Sequence Accession number 
Mouse   
Tnfr1 Forward: GTGCGTCCCTTGCAGCCACT NM_0116094 
Reverse: GCAACAGCACCGCAGTAGCTGA  
Ripk1 Forward: GACTGTGTACCCTTACCTCCGA NM_009068 
Reverse: CACTGCGATCATTCTCGTCCTG  
Ripk3 Forward: GAAGACACGGCACTCCTTGGTA NM_019955 
Reverse: CTTGAGGCAGTAGTTCTTGGTGG  
Mlkl Forward: CTGAGGGAACTGCTGGATAGAG NM_001310613 
Reverse: CGAGGAAACTGGAGCTGCTGAT  
Casp8 Forward: ATGGCTACGGTGAAGAACTGC NM_009812 
Reverse: TAGTTCACGCCAGTCAGG  
Fadd Forward: CACACAATGTCAAATGCCACCTG NM_01017 
Reverse: TGCGCCGACACGATCTACTGC  
Ciap1/2 Forward: GGACATTAGGAGTCTTCCCACAG NM_007464 
Reverse: GAACACGATGGATACCTCTCGG  
Gpx4 Forward: CCTCTGCTGCAAGAGCCTCCC NM_001037741 
Reverse: CTTATCCAGGCAGACCATGTGC  
Ppif (CypD) Forward: GGACGCTTGAAAATGTAGAGGTG NM_026352 
Reverse: GGATGACTGTCACCAGAGCCAT  
Casp1 Forward: TCAGCTCCATCAGCTGAAAC NM_009807 
Reverse: TGGAAATGTGCCATCTTCTTT  
Nlrp3 Forward: TCACAACTCGCCCAAGGAGGAA NM_145827 
Reverse: AAGAGACCACGGCAGAAGCTAG  
Parp1 Forward: CTCTCCCAGAACAAGGACGAAG NM_007415 
Reverse: CCGCTTTCACTTCCTCCATCTTC  
 
 
 
 
 
 
 
 
 
 
 
Tnfr1: Tumor necrosis factor receptor 1, Ripk1: receptor-interacting serine/threonine-protein 
kinase 1, Ripk3: receptor-interacting serine/threonine-protein kinase 3, Mlkl: mixed lineage kinase 
domain like pseudokinase, Casp8: cysteine-aspartic acid protease 8, Fadd: Fas-associated protein 
with death domain, Ciap1/2: cellular inhibitor of apoptosis protein 1, Gpx4: glutathione peroxidase 
4, CypD: cyclophilin D, Casp1: cysteine-aspartic acid protease 1, NLRP3: nod-like receptor family 
pyrin domain containing 3,  Parp1: Poly [ADP-ribose] polymerase 1. Honarpisheh M, et al.3 
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4. Results 
 
4.1. Expression of regulated necrosis-related genes in acute tissue injury 
 
We first sought to determine the expression level of necroptosis- and other regulated-necrosis-
related genes in various AKI models such as ischemia-reperfusion injury, acute oxalate 
nephropathy, and cisplatin nephropathy. We performed histochemistry staining for H&E and 
PAS to evaluate the extent of injury in our models compared to the baseline level. PAS, H&E 
staining, and tubular injury score reveal the kidney damage after induction of acute kidney 
injury in mice (Figure 3A-C). We selected genes that are associated with necroptosis (Tnfr1, 
Ripk1, Ripk3, Mlkl, Fadd, and cIAP-1/2), ferroptosis (Gpx4), MPT-RN Ppif (CypD), 
pyroptosis (Nlrp3 and caspase-1), and parthanatos (Parp1) pathways and performed RT-PCR, 
to quantify the mRNA expression levels of those genes. We observed high expression levels 
of necroptosis-related mRNAs such as Ripk3, Mlkl, and cIAP-1/2 in all three mouse models of 
AKI compared to baseline (Figures 4A-B). In addition, Casp1, Nlrp3 mRNAs were highly 
induced only in IRI and Tnfr1, Casp8 mRNA expression levels were significantly increased 
only in acute oxalate nephropathy, whereas Ripk1, Casp8, Fadd, Ppif (CypD), and Parp1 
mRNA levels were significantly down-regulated in cisplatin-induced nephropathy (Figure 3A-
B). However, Gpx4 mRNA expression level did not change in all three acute tissue injury 
models (Figures 4A-B). Then, we checked the main proteins involved in the necroptosis 
pathway Ripk3 and Mlkl via immunostaining, and we found that both proteins Ripk3 and Mlkl 
increased in all three models (Figure 5). Together, these data show that the necroptosis pathway 
might be involved in all acute kidney injury, whereas the induction of regulated necrosis 
pathway is highly dependent on the trigger. 
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Figure 3. PAS and H&E staining in acute kidney injury. Three animal models of acute kidney 
injury including IRI, oxalate nephropathy, and cisplatin were induced as described in detail in the 
methods. (A) PAS was used to stain kidney sections, Original magnification:×100 (B) H&E was 
used to stain kidney sections. Original magnification: x200. (C) Quantification of tubular injury 
is indicated as percentage. Data presented as means ± SEM. ***P<0.001 either versus control. 
PAS: periodic acid–Schiff, H&E: Hematoxylin and eosin. 
Honarpisheh M, et al.3 
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Figure 4. Expression of necrosis-related mRNA levels in acute kidney injury. (A) Real-time 
RT-PCR was carried out from the injured kidneys. To normalize the expression level of mRNA 
18s rRNA was used as an internal control. The histogram graph shows the level of expression 
of various genes in the wild-type kidney (control). Data presented as means ± S.E.M. The 
heatmap shows the relative expression of genes of interest in different models compared with 
wild-type control group. (B) Volcano plots reveal a significant up-regulation and down-
regulation of different genes in injured kidneys compared to control kidneys. ***P < 0.05 
indicated as statistically significant. Dotted lines represent P = 0.05.   
 Honarpisheh M, et al.3 
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4.2. Differential regulation of necrosis-related genes in chronic oxalate 
nephropathy  
 
Progression of tissue injury leads to chronic tissue remodelling175, 176  and several inflammatory 
cells infiltrate into the injury site and promote fibrosis by producing  pro-fibrotic proteins.177,178  
To investigate the change in expression levels of regulated necrosis-related genes, we made 
use of the well-established murine model of chronic oxalate nephropathy.171 For this, mice 
were fed an oxalate-rich diet containing 50 μmol/g sodium oxalate in a calcium-free standard 
chow diet, 171 and sacrificed on day 7, 14 and 21. PAS, alpha-SMA, and collagen 1α1 staining 
showed progression of kidney damage starting from day 7, which further increased until day 
21 (Figure 6A). In addition, tubular injury as the hallmark of kidney damage significantly 
increased upon feeding mice an oxalate-rich diet at day 7, 14 and 21 (Figure 6B). This was 
consistent with more fibrotic lesions as indicated by alpha-SMA and collagen 1α1 (Figure 6A). 
 
 
 
Figure 5. Increase expression level of Ripk3 and Mlkl in acute organ injury. Immunostaining 
of kidney sections from mice with AKI that were stained for RIPK3 and MLKL, Original 
magnification: ×100. Ripk3: receptor interacting serine/threonine kinase 3, Mlkl: mixed lineage 
kinase domain-like pseudokinase. 
Honarpisheh M, et al.3 
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Figure 6. PAS, H&E and collagen 1a1 staining in chronic oxalate nephropathy. (A) 
Representative images of kidney sections stained for PAS, SMA on day 0, 7, 14 and 21. Original 
magnification: ×100 and collagen 1a1 at day 0, 7, 14 and 21. Original magnification: x200. (B) 
PAS injury score was determined as described in the method and material section. Data presented 
as means ± SEM. ***P<0.001 either versus day 0. PAS: Periodic acid–schiff, H&E: hematoxylin 
and eosin. SMA: smooth muscle actin. 
Honarpisheh M, et al.3 
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Next, we checked the expression levels of regulated necrosis-related molecules in chronic 
oxalate nephropathy. As expected, the mRNA as well as protein expression levels of the 
necroptosis-specific genes Ripk3 and Mlkl significantly increased on day 7 and 14 (Figures 
7A-B and 8). Of note, the mRNA and protein expression levels of Ripk3 were still significantly 
higher compared to mRNA and protein expression level of Mlkl (Figures 7A-B and 8). In 
addition, the upstream genes of the necroptosis pathway Tnfr1 and cIAP1/2 were significantly 
increased as well as the pyroptosis-related genes Nlrp3 and Casp1 during the chronic oxalate 
nephropathy on day 7, 14 and 21, whereas, Ripk1, Casp8, Fadd, Gpx4, Ppif (CypD), and Parp1 
mRNA expressions significantly decreased (Figures 7-B and 8). Taken together, the data show 
that necroptosis might be involved in chronic oxalate nephropathy by activating Ripk3 and 
Mlkl proteins. 
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Figure 7. Expression of necrosis-related mRNA levels in chronic oxalate 
nephropathy. (A) RT-PCR was performed on the damaged kidneys at day 0, 7, 14 and 21 
and the mRNA expression level normalized to 18s rRNA as an internal control. The bar 
graph shows the expression levels of various genes of wild-type kidney (control). Data 
presented as means ± S.E.M. The heatmap shows the expression of mRNA levels at day 7, 
14 and 21 compared with day 0. (B) Volcano graphs show significant up- and down-
regulation of various genes in damaged kidneys at day 7, 14 and 21 compared with day 
0.  ***P < 0.05 indicated as statistically significant. Dotted lines represent P = 0.05.  RT-
PCR: real-time polymerase chain reaction. 
Honarpisheh M, et al.3 
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4.3. Crystalline particles induce cell death in human tubular epithelial cells 
 
Next, we investigated whether metabolic and environmental crystals can induce cell death and 
whether their specific shape and size have an effect on cell death. To address this issue, we 
used various environmental and metabolic crystalline particles with different shapes and sizes 
including, CaP (rhomboid and prism shape, 0.2–1 µm size), silica (sphere shape, 1–1.5 µM 
size), TiO2 (sphere shape, 80 nm size), cholesterol (rhomboid shape, 0.2–1.5 µm size), CaOx 
(rhomboid and prism shape, 1–2 µm size), and MSU (needle-like shape, 1–2 µm size). We 
visualized all crystals by light microscopy and TEM; all crystals had completely different sizes 
and shapes. As shown in (Figure 9A-B). To check the cytotoxicity of these crystals, HK2 cells 
were exposed to different concentrations of CaP (0.15, 0.25, 0.5 and 1 mg/ml), silica, TiO2 
(0.15, 0.25 and 0.5 mg/ml), cholesterol (1, 2, and 3 mg/ml), CaOx (0.15, 0.25, 0.5 and 1 mg/ml), 
MSU (0.15, 0.25 and 0.5 mg/ml) for 24 hours. The LDH assay revealed that all crystals were 
able to induce cell death in a dose-dependent manner (Figure 10). In further experiments, we 
selected only one concentration of each crystal type for CaP 1mg/ml, TiO2 0.5 mg/ml, 
Figure 8. Increase expression level of Ripk3 and Mlkl proteins in chronic oxalate 
nephropathy at day 0, 7, 14 and 21. Kidneys from mice with chronic oxalate nephropathy were 
harvested  and kidney sections stained to determine Ripk3 and Mlkl protein expression level on 
day 0, 7, 14 and 21. Original magnification: ×100 and collagen1a1 at day 0, 7, 14 and 21. Original 
magnification: x200. Ripk3: Receptor Interacting Serine/Threonine Kinase 3, Mlkl: mixed 
lineage kinase domain-like pseudokinase. 
Honarpisheh M, et al.3 
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cholesterol 3 mg/ml, CaOx 1 mg/ml, and MSU 0.5 mg/ml, and applied PI (for staining the 
death cells) and acridine orange (for staining the live cells) staining after 24 hours stimulation 
to confirm the LDH assay data. Those cells that died upon crystal stimulation were positive for 
PI (red color) whereas, the live cells were positive for acridine orange (green color) (Figure 
11A). Fluorescence imaging revealed that crystals induced an increase in the mean 
fluorescence intensity (MFI) of PI compared to untreated cells (Figure 11B). Taken together, 
these data clearly showed that crystals regardless of their sizes and shapes were able to induce 
cell death in HK2 cells. 
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Figure 9. Light microscopy and transmission electron microscopy of crystalline particles. 
(A) Light microscopy, and (B) TEM was used to show differences in the size and shape of 
crystals including CaP, silica, cholesterol, and TiO2 nanoparticles. TEM: transmission 
electron microscopy, CaP: calcium phosphate, TiO2: titanium dioxide. 
Honarpisheh M, et al.1 
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Figure 10. Crystalline particles induce cell death in HK2 cells. HK2 cells were stimulated 
with CaP, silica, TiO2, cholesterol, CaOx, and MSU crystals at various concentrations for 
24 hours. The LDH was used to check cytotoxicity of crystals. Data are presented as mean 
± SEM from three independent experiments, *p<0.05, *** p<0.001. n.s. = not significant 
vs vehicle. LDH: Lactate dehydrogenase. Honarpisheh M, et al.1 
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Figure 11. Crystalline particles induce cytotoxicity in HK2 cells. (A) HK2 cells were stimulated 
with 1 mg/ml CaP, 1 mg/ml silica, 0.5 mg/ml TiO2, 3 mg/ml cholesterol, 1 mg/ml CaOx, and 0.5 
mg/ml MSU crystals for 24 hours. Cells were stained with PI in red color and acridine orange in 
green color. (B) PI signals were quantified and represented as MFI. Data are presented as 
mean±SEM from three independent experiments, *p<0.05, *** p<0.001. n.s. = not significant vs 
vehicle.  CaP: calcium phosphate, TiO2: titanium dioxide, CaOx: calcium oxalate,MSU: 
monosodium urate, PI: propidium iodide, MFI: mean fluorescence intensity. 
Honarpisheh M, et al.1 
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4.4. Crystalline particles induce primary necrosis in human tubular epithelial 
cells 
 
To investigate the mechanism of crystalline particle-induced cell death, we carried out multi-
color flow cytometry and determined the type of cell death based on the positivity of hoechst 
33342, annexin V-FITC, 1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate 
(DiLC1) or PI staining. We found that environmental and metabolic crystalline particles of 
different sizes and shapes mostly induced primary necrosis (annexinV-FITC+, PI high, 
DilC1(5)low) in HK2 cells (Figure 12). Secondary necrotic cells were identified as annexinV-
FITC+, PI low, DilC1(5)low-int and apoptotic cells as annexinV-FITC+, PI−, DilC1(5)int-
high174 (Figure 12). To investigate the role of apoptosis in crystals induced cell death, we used 
the pan-caspase inhibitor zVAD-FMK to block apoptosis. As shown in Figure 13, blocking 
apoptosis with zVAD-FMK did not reduce the PI positive signal in HK2 cells stimulated with 
crystals (Figure 13). Taken together, we conclude that crystals or crystalline particle-induced 
cell death mainly involves primary necrosis (necroptosis) and not apoptosis because this 
crystal-induced cell death was independent of caspase activity. 
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Figure 12.Crystals induce primary necrosis in HK2 cells. HK2 cells were stimulated with 1 mg/ml 
CaP, 1 mg/ml silica, 0.5 mg/ml TiO2, 3 mg/ml cholesterol, 1 mg/ml CaOx, and 0.5 mg/ml MSU 
crystals for 24 hours. Multicolor FACS was used to determine different types of cell death as 
described in the material and method section. Analysis revealed primary necrosis as main form of 
cell death in crystal-induced HK2 cells. Primary necrotic cells were identified as annexinV-FITC+, 
PI high, DilC1 (5) low, and secondary necrotic cells as annexinV-FITC+, PI low, DilC1(5)low-int, 
and apoptosis: annexinV-FITC+, PI−, DilC1(5)int-high. CaP: calcium phosphate, TiO2: titanium 
dioxide, CaOx:calcium oxalate,  MSU: monosodium urate, FITC: fluorescein isothiocyanate, PI: 
propidium iodide, DilC1(5): 1,1′,3,3,3′,3′-hexamethylindodicarbo - cyanine iodide. Honarpisheh M, 
et al.1 
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Figure 13.  Cell death analysis of HK2 cells expose to crystalline particles in presence or 
absence of zVAD. (A) HK2 cells were pretreated with zVAD-FMK, a pan-caspase inhibitor (10 
µl) for 30 minutes prior to stimulation with 1 mg/ml CaP, 1 mg/ml silica, 0.5 mg/ml TiO2, 3 
mg/ml cholesterol, 1 mg/ml CaOx, and 0.5 mg/ml MSU crystals for 24 hours. Cells were stained 
with PI. (B) PI was quantified and represented as MFI with ImageJ software. Data are presented 
as mean ± SEM from three independent experiments, *p<0.05, *** p<0.001. n.s. = not significant 
vs vehicle.   
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4.5. Necroptosis inhibition with chemical inhibitors of RIPK1, RIPK3, and 
MLKL reduce crystal-induced cell necrosis 
 
To confirm the involvement of the necroptosis pathway in crystal-induced cell death we used 
the RIPK1 inhibitor Nec1s, the RIPK3 inhibitor dabrafenib and the MLKL inhibitor NSA. HK2 
cells were pre-treated with Nec1s (100 µM), dabrafenib (10 µM) and NSA (5 and 10 µM) 30 
minutes prior stimulation with different crystals, including CaP (1 mg/ml), silica (1 mg/ml), 
TiO2 (0.5 mg/ml), cholesterol (3 mg/ml), CaOx (1 mg/ml), and MSU (0.5 mg/ml) for up to 24 
hours. Cell death was analysed via PI and acridine orange staining (Figure 14A-B and 15A-B). 
Stimulation of HK2 cells with crystals resulted in an increased PI positivity (Figure 14A-B 
and15A-B), a cytotoxic effect that was significantly reduced in the presence of the 
inhibitorsNec1s, dabrafenib and NSA. In addition, we also checked for cellular toxicity of 
crystals in HK2 cells using the LDH assay. To do so, HK2 cells were pre-treated with Nec1s 
(100 µM), dabrafenib (10 µM), and NSA (5 and 10 µM) prior to stimulation with crystals for 
24 hours and supernatants were collected. The results showed that all three necroptosis 
inhibitor reduced the LDH signals compared with vehicle-treated crystal-stimulated HK2 cells 
(Figure 16A-B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
CaP: calcium phosphate, TiO2: titanium dioxide, CaOx: calcium oxalate, MSU: monosodium urate, 
PI: propidium iodide. MFI: mean fluorescence intensity.  
Honarpisheh M, et al.1 
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Figure 14. Necroptosis inhibitors reduce cell death in HK2 cell in presence of crystalline 
particles. (A) HK2 cells were pretreated with Nec1s (100 μM), dabrafenib (10 μM) for 30 
minutes prior to stimulation with 1 mg/ml CaP, 1 mg/ml silica, 0.5 mg/ml TiO2, 3 mg/ml 
cholesterol, 1 mg/ml CaOx, and 0.5 mg/ml MSU crystals for 24 hours. After stimulation, cells 
were stained with PI in red color and acridine orange in green color. Images were taken from 
the PI staining and converted into black and white using ImageJ software. (B) PI quantification 
is presented as MFI. Data are expressed as mean ± SEM from three independent experiments, 
*p<0.05, *** p<0.001. n.s. = not significant vs vehicle. CaP: calcium phosphate, TiO2: 
titanium dioxide, CaOx: calcium oxalate, MSU: monosodium urate, PI: propidium iodide. 
MFI: mean fluorescence intensity, Nec1s: Necrostatin-1s.  
Honarpisheh M, et al.1 
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Figure 16. MLKL inhibitor (NSA) decrease cell death in HK2 cells. HK2 cells were pretreated 
with Nec1s (100 μM), dabrafenib (10 μM) or NSA (5 μM and 10 μM) for 30 minutes prior to 
stimulation with 1 mg/ml CaP, 1 mg/ml silica, 0.5 mg/ml TiO2, 3 mg/ml cholesterol, 1 mg/ml 
CaOx, and 0.5 mg/ml MSU  crystals for 24 hours. LDH assay was used to analyze cell death after 
24 hours by quantifying the LDH release in cell culture supernatants. Data are presented as mean 
± SEM from three independent experiments, *p<0.05, *** p<0.001. n.s. = not significant vs 
vehicle. CaP: calcium phosphate, TiO2: titanium dioxide, CaOx: calcium oxalate, MSU: 
monosodium urate, PI: propidium iodide. MFI: mean fluorescence intensity, NSA: 
necrosulfonamide, Nec1s: necrostatin-1s, LDH: lactate dehydrogenase 
Honarpisheh M, et al.1 
 
Figure 15. MLKL inhibitor (NSA) decrease cell death in HK2 cells. (A) HK2 cells were pretreated 
with NSA (5 µM and 10 µM) 30 minutes prior to stimulation with 1 mg/ml CaP, 1 mg/ml silica, 0.5 
mg/ml TiO2, 3 mg/ml cholesterol, 1 mg/ml CaOx, and 0.5 mg/ml MSU crystals for 24 hours. Cells were 
stained with PI in red color and acridine orange in green color. Images collected from PI staining were 
converted into black and white using ImageJ software. (B) PI quantification is presented as MFI. Data 
are expressed as mean ± SEM from three independent experiments, *p<0.05, *** p<0.001. n.s. = not 
significant vs vehicle. CaP: calcium phosphate, TiO2: titanium dioxide, CaOx: calcium oxalate, MSU: 
monosodium urate, PI: propidium iodide. MFI: mean fluorescence intensity, NSA: necrosulfonamide. 
Honarpisheh M, et al.1 
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4.6. RIPK3 knock-down or Mlkl deficiency reduce cytotoxicity of crystalline 
particles in human and mouse tubular epithelial cells 
 
In addition, we applied a genetic approach to further validate our results, because of potential 
off-target effects of the chemical necroptosis inhibitors. To address this issue, we knocked 
down RIPK3 using siRNA with a Neon electroporation system. HK2 cells were transfected 
with 120 nm of siRNA against the RIPK3 or scramble control group for 48 hours. The 
electroporation parameters were optimized for HK2 as described in the method and material 
section and the transfection efficacy was evaluated using RT-PCR for RIPK3 mRNA levels 
(Figure 17). After optimization, transfected HK2 cells were stiumulated with 1 mg/ml CaP, 1 
mg/ml silica, mg/ml TiO2 0.5, 3 mg/ml cholesterol, 1 mg/ml CaOx, and 0.5 mg/ml MSU 
crystals, and cell death determined by quantification of PI positivity and LDH assay. As 
expected, the number of PI positive HK2 cells and LDH levels were reduced in transfected 
HK2 cells with siRNA-Ripk3 compared to scramble siRNA upon stimulation with various 
crystal types (Figure 18A-C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. siRNA against RIPK3 decrease RIPK3 mRNA level in HK2. Transfection of HK2 
cells was carried out using 120 nm of siRNA against RIPK3 or scramble group for 48 hours. 
The efficiency of siRNA was checked by RT-PCR for RIPK3. Data are expressed as mean ± 
SEM from three independent experiments, *p<0.05, *** p<0.001. n.s. = not significant vs 
vehicle. RIPK3: receptor interacting serine/threonine kinase 3. 
Honarpisheh M, et al.1 
 
 
 
   Results                                                                                                                                            54 
 ________________________________________________________________________________  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A                                                                              B                                                                                                
B                                             
C
a
P
 
S
il
ic
a
 
T
iO
2
 
C
h
o
l 
C
a
O
x
 
M
S
U
 
scramble group       siRNA-Ripk3                                                                              
B                                                                                                
0 .0 0
0 .0 2
0 .0 4
0 .0 6
0 .0 8
0 .1 0
D
N
A
 P
I 
(
M
F
I) ***
0 .0 0
0 .0 5
0 .1 0
0 .1 5
***
D
N
A
 P
I 
(
M
F
I)
0 . 0 0
0 .0 5
0 .1 0
0 .1 5
***
D
N
A
 P
I 
(
M
F
I)
0 . 0 0
0 .0 2
0 .0 4
0 .0 6
0 .0 8
**
D
N
A
 P
I 
(
M
F
I)
0 . 0
0 .1
0 .2
0 .3
***
D
N
A
 P
I 
(
M
F
I)
0 . 0 0
0 .0 5
0 .1 0
0 .1 5
0 .2 0
0 .2 5
***
D
N
A
 P
I 
(
M
F
I)
   Results                                                                                                                                            55 
 ________________________________________________________________________________  
 
In addition, we used Mlkl- deficient primary tubular epithelial cells to confirm the role of Mlkl 
in crystal-induced cell death. To do so, Mlkl- deficient primary tubular epithelial cells were 
stimulated with 1 mg/ml CaP crystals, 1 mg/ml silica, 0.5 mg/ml TiO2, 3 mg/ml cholesterol, 1 
mg/ml CaOx, and 0.5 mg/ml MSU for 24 hours, and cell death was visualized and quantified 
by PI positive signal and LDH assay. We found that primary tubular epithelial cells isolated 
from Mlkl-deficient mice were protected from crystal- induced cell death regardless of sizes, 
shapes and origin of the particles (environmental or metabolic) (Figures 19A-B and 20). 
Interestingly, we saw different trends of protection between crystalline particles, which suggest 
the possible impact of particle types, different sizes and specific-shapes on regulated cell death. 
Taken together, we conclude that crystal-induced cell death involves necroptosis and that 
blocking Ripk1, Ripk3, and Mlkl consistently abrogates the cytotoxic effect of environmental 
or metabolic crystalline particles, whereas inhibiting apoptosis had no effect (Figure 13A-B).  
C 
Figure 18. siRNA against RIPK3 reduce cytotoxic effect of crystalline particles in HK2 cells (A) 
Transfected HK2 cells with siRNA-RIPK3 were stimulated with 1 mg/ml CaP, 1 mg/ml silica, 0.5 
mg/ml TiO2, 3 mg/ml cholesterol, 1 mg/ml CaOx, and mg/ml MSU 0.5 crystals for 24 hours. Cells 
were stained with PI (B) and the PI positive signals quantified by ImageJ. (C) LDH release was 
measured in cell culture supernatants. Data are expressed as mean ± SEM from three independent 
experiments, *p<0.05, *** p<0.001. n.s. = not significant vs vehicle.  CaP: calcium phosphate, TiO2: 
titanium dioxide, CaOx: calcium oxalate, MSU: monosodium urate, PI: propidium iodide. MFI: 
mean fluorescence intensity. 
Honarpisheh M, et al.1 
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A                                                                                   B                                                                                                                 
B 
Figure 19. Mlkl-deficient cells reduce cytotoxic effect of crystalline particles in primary tubular 
epithelial cells. (A) Freshly isolated pTECs from Mlkl-deficient and wild-type mice were stimulated 
with 1 mg/ml CaP, 1 mg/ml silica, 0.5 mg/ml TiO2, 3 mg/ml cholesterol, 1 mg/ml CaOx, and 0.5 
mg/ml MSU crystals for 24 hours. The stimulated as well as untreated cells were stained with PI in 
red color and acridine orange in green color. The images collected were also visualized in black and 
white using ImageJ software. (B) The PI signals were quantified and represent as MFI. Data are 
presented as mean±SEM from three independent experiments, *p<0.05, *** p<0.001. n.s. = not 
significant vs vehicle.  
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4.7. Phagocytosis precedes crystalline particle-induced cell death 
 
It has been shown that CaOx crystals can be internalized by renal tubular kidney cells via 
phagocytosis.179 We speculate that same process might also be the case for other environmental 
or metabolic crystalline particles, and subsequently leading to cell death. To check this concept, 
we used CytD an actin polymerization inhibitor to block phagocytosis. HK2 cells were pre-
treated with CytD (10µM) for 30 minutes before exposing them to CaP, silica, TiO2, 
cholesterol, CaOx and MSU. Cell death was quantified using PI staining. Interestingly, we 
observed that the cytotoxicity of crystalline particles was significantly reduced upon 
pretreatment with CytD (Figure 21A-B). These results indicate that the internalization of 
crystalline particles is essential to activate the necroptosis pathway and subsequently leading 
to cell death.  
 
 
CaP: calcium phosphate, TiO2: titanium dioxide, CaOx: calcium oxalate, MSU: monosodium 
urate, PI: propidium iodide, MFI: mean fluorescence intensity. Honarpisheh M, et al.1 
 
 
Figure 20. Exposure of Mlkl-deficient cells to crystalline particles. Freshly isolated pTECs from 
wild-type and Mlkl-deficient mice were stimulated with 1 mg/ml CaP, 1 mg/ml silica, 0.5 mg/ml 
TiO2, 3 mg/ml cholesterol, 1 mg/ml CaOx, and 0.5 mg/ml MSU crystals for 24 hours LDH assay 
was used to analyze cell death after 24 hours. Data are presented as mean ± SEM from three 
independent experiments, *p<0.05, *** p<0.001. n.s. = not significant vs vehicle. CaP: calcium 
phosphate, TiO2: titanium dioxide, CaOx: calcium oxalate, MSU: monosodium urate, PI: 
propidium iodide, MFI: mean fluorescence intensity. 
Honarpisheh M, et al.1 
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4.8. Mitochondrial damage upon the crystals stimulation 
 
Inhibiting necroptosis either with pharmaceutical inhibitors or using genetic approach did not 
completely protect the cells from crystal-induced cytotoxicity. These observations led us to ask 
the question whether another caspase-independent cell death pathway might be involved in 
crystal-induced cell and tissue injury or not. Previously, Linkermann et al. showed that MPT 
is involved in renal ischemia-reperfusion injury independent of necroptosis.111 Therefore, we 
intended to explore the possible involvement of the MPT pathway in crystal-induced tissue and 
cell injury. To answer our questions, we focused on four crystalline particles CaOx, MSU, 
silica and CPPD, all being involved in important diseases. For example, CaOx crystal particles 
lead to acute oxalate nephropathy and nephrolithiasis4, MSU prompts gout and urate 
nephropathy4, silica particles induce pneumoconiosis and silicosis4, and CPPD could be 
involved in pseudogout, chondrocalcinosis, and hemochromatosis.4 A hallmark of 
mitochondrial damage is the loss of cristae as well as swollen mitochondria under stress 
conditions. Thus, we first evaluated the mitochondrial ultrastructure by TEM. L929 cells were 
exposed to 1 mg/ml CaOx, 1 mg/ml MSU, 0.5 mg/ml SiO2 and 0.5 mg/ml CPPD crystals for 
24 hours. As shown in Figure 22, all crystalline-particles induced mitochondrial swelling and 
loss of cristae in L929 cells (Figure 22), which suggests that mitochondria could be involved 
in crystalline particle-induced cytotoxicity. 
 
 
 
 
Figure 21. Cell death analysis of the HK2 cells in the presence or absence of a phagocytosis 
inhibitor. HK2 cells were pre-treated with the phagocytosis inhibitor Cyt D (10 µM) 30 minutes 
prior to stimulation with 1 mg/ml CaP, 1 mg/ml silica, 0.5 mg/ml TiO2, 3 mg/ml cholesterol, 1 
mg/ml CaOx, and 0.5 mg/ml MSU crystals for 24 hours. (A) Cells were stained with PI in red color 
and acridine orange in green colour. Images collected from PI staining were converted into black 
and white using ImageJ software. (B) PI signals were quantified and represent as MFI. Data are 
presented as mean ± SEM from three independent experiments, *p<0.05, **** p<0.001. n.s. = not 
significant vs vehicle. CaP: calcium phosphate, TiO2: titanium dioxide, CaOx: calcium oxalate, 
MSU: monosodium urate, PI: propidium iodide. MFI: mean fluorescence intensity. CytD. 
cytochalasin D. 
Honarpisheh M, et al.1 
 
 
 
 
 
 
   Results                                                                                                                                            60 
 ________________________________________________________________________________  
 
 
Next, we sought to investigate mitochondrial functions such as ROS production, MOMP and 
finally, mitochondrial cell death in response to crystals. To do this, we used the dye TMRE to 
measure the membrane potential, DCFDA to analyze ROS production and calcein/ PI to 
analyze cell death. L929 cells were incubated with CaOx 1 mg/ml, MSU 1 mg/ml, SiO2 0.5 
mg/ml, and CPPD 0.5 mg/ml crystals for 24 hours. We observed that the TMRE positive signal 
was present in the mitochondria of healthy cells and significantly declined upon exposure to 
crystals (Figure 23A), indicating loss of membrane potential in mitochondria. Interestingly, we 
observed an increase in ROS production and cell death upon crystals' exposure to the cells 
(Figures 23B and 23C). Altogether, we conclude that the cytotoxic effects of crystalline 
particles are associated with mitochondrial permeability transition. 
 
 
 
 
 
 
 
 
 
Figure 22. Transmission electron microscopy images show mitochondrial damage in L929 
cells. L929 cells were stimulated with, MSU, silica, and CPPD crystals for 24 hours. Images 
collected from TEM show that crystals induce mitochondrial damage as illustrated by a loss of 
cristae and swollen mitochondria (scale bar 250 nm). TEM: Transmission electron microscopy, 
CaOx: calcium oxalate, MSU: monosodium urate, CPPD: calcium pyrophosphate dehydrate. 
Mulay SR, Honarpisheh MM, et al.2 
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4.9. Inhibition of Ppif, a mitochondrial outer membrane protein, and ROS 
production reduce crystal cytotoxicity 
 
To investigate whether mitochondrial outer membrane proteins and ROS production are 
involved in crystal cytotoxicity, we blocked mitochondrial membrane protein cyclophilin and 
ROS production. L929 cells were pre-treated with Ppif inhibitor CsA and ROS inhibitor APDC 
as for 30 minutes followed by stimulation with CaOx 1 mg/ml, MSU 1 mg/ml, SiO2 0.5 mg/ml 
and CPPD 0.5 mg/ml crystals for 24 hours. We found that the mitochondrial membrane 
potential was fully reversed when CsA was added to crystal-stimulated L929 cells (Figure 24). 
However, the mitochondrial membrane potential was not fully reversed in the presence of 
Control                      CaOx                      Silica                   MSU                         CPPD  
A 
 
B 
 
C 
Figure 23. Live cell staining to visualize mitochondrial membrane potential, ROS 
production and cell death in L929 cells. (A) TMRE staining was used to determine MOMP 
damage. Images show loss of membrane potential after cells were stimulated with 1 mg/ml 
CaOx, 1 mg/ml MSU, 0.5 mg/ml silica, and 0.5 mg/ml CPPD crystals for 24 hours (scale bar 
25 μm). (B) DCFDA staining was used to check for ROS production. Images show that 
stimulation cells with crystals leads to ROS production (scale bar 25 μm). (C) Cells were stained 
with calcein for live cells in green and PI for dead cells in red, and show cellular necrosis after 
crystal stimulation (scale bar 25 μm).  CaOx: calcium oxalate, MSU: monosodium 
urate,CPPD: calcium pyrophosphate dehydrate MOMP : mitochondrial outer membrane 
potential,  ROS: reactive oxygen species,   TMRE: tetramethylrhodamine ethyl ester,  DCFDA: 
2',7'-dichlorodihydrofluorescein diacetate. 
Mulay SR, Honarpisheh MM, et al.2 
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antioxidant APDC (Figure 24), which indicates that ROS production is downstream of losing 
mitochondrial membrane potential. Interestingly, ROS production and cell death significantly 
decreased in the presence of CsA and APDC (Figures 25 and 26). 
 
 
 
 
 
 
 
Figure 24. Quantification of live cell staining in the absence or presence of ROS and Ppif 
inhibitors to analyze mitochondrial membrane potential in L929 cells. L929 cells were 
pre-treated with CsA (1 μM) and (APDC, 200 μM) for 30 minutes prior to stimulation with 1 
mg/ml CaOx, 1 mg/ml MSU, 0.5 mg/ml silica, and 0.5 mg/ml CPPD crystals for 24 hours. 
TMRE staining was used to determine MOMP damage. Results were expressed as MFI (n=10-
12). Data are representative of three independent experiments. One-way ANOVA was used to 
analyze data and are expressed as mean  SEM. *p<0.05, *** p<0.001. n.s. = not significant 
vs vehicle. CaOx: calcium oxalate, MSU: monosodium urate, CPPD: calcium pyrophosphate 
dehydrate CsA: cyclosporine A, APDC: antioxidant ammonium pyrrolidine 
dithiocarbamate,MOMP: mitochondrial outer membrane potential, TMRE: 
tetramethylrhodamine ethyl ester, MFI: mean fluorescent intensity. 
Mulay SR, Honarpisheh MM, et al.2 
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Figure 25. Quantification of live cell staining in the absence or presence of ROS and Ppif 
inhibitors to analysis ROS production in L929 cells. L929 cells were pre-treated with CsA 
(1 μM) and APDC (200 μM) for 30 minutes prior to stimulation with CaOx 1 mg/ml, MSU 1 
mg/ml , SiO2 0.5 mg/ml and CPPD 0.5 mg/ml crystals for 24 hours. DCFDA staining was 
used to check ROS production and results are expressed as MFI (n=10-12). Data are 
representative of three independent experiments. One-way ANOVA was used to analyze data 
and are expressed as mean  SEM. *p<0.05, *** p<0.001. n.s. = not significant vs vehicle. 
CaOx: calcium oxalate, MSU: monosodium urate,  CPPD: calcium pyrophosphate dehydrate 
CsA: cyclosporine A, APDC: antioxidant ammonium pyrrolidine dithiocarbamate, MFI: 
mean fluorescent intensity, SiO2: silica. DCFDA: 2',7'-dichlorodihydrofluorescein diacetate. 
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To confirm the previous results, we used specific siRNA against Ppif as well as isolated 
primary tubular epithelial cells from wild-type and Ppif-deficient mice. We observed that cell 
death was significantly reduced in Ppif siRNA knockdown L929 cells as well as primary 
tubular epithelial cells isolated from Ppif-deficient mice in comparison to scramble or cells 
from wild-type mice after stimulation with CaOx 1 mg/ml, MSU 1 mg/ml, silica 0.5 mg/ml 
and CPPD 0.5 mg/ml crystals for 24 hours. (Figure 27A-D). We conclude that crystal 
cytotoxicity involves MPT , a form of cell death dependent on Ppif protein and ROS release. 
 
 
 
 
 
Figure 26.  ROS and Ppif inhibitors reduce cytotoxic effect of crystalline particles in 
L929 cells. L929 cells were pre-treated  with CsA (1 μM) and APDC (200 μM) for 30 
minutes prior to stimulation with CaOx 1 mg/ml, MSU 1 mg/ml, SiO2 0.5 mg/ml and CPPD 
0.5 mg/ml crystals for 24 hours. Cells were stained with calcein for live cells (green) and 
PI for dead cells (red). Data are representative of three independent experiments. One-way 
ANOVA was used to analyze data and are expressed as mean  SEM. *p<0.05, *** 
p<0.001. n.s. = not significant vs vehicle. CaOx: calcium oxalate, MSU: monosodium 
urate,CPPD: calcium pyrophosphate dehydrate CsA: cyclosporine A, APDC: antioxidant 
ammonium pyrrolidine dithiocarbamate, SiO2: silica. 
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Figure 27. siRNA-Ppif or Ppif-deficient cells reduce cell death in L929 cell. (A-B) L929 cells 
were transfected with siRNA-Ppif or a scrambled control before cells were stimulated with 
crystals as mentioned above. (A) Cells were stained with PI and (B) signals were quantified using 
ImageJ that are expressed as MFI (n=9-12). (C-D) Freshly isolated pTECs from Ppif-deficient 
and wild-type mice were stimulated with crystals as mentioned above. (C) Cells were stained 
with PI and (D) signals were quantified using ImageJ that are expressed as MFI (n=8-12) (B). 
Data are representative of three independent experiments. One-way ANOVA was used to analyze 
data and are expressed as mean ± SEM. *p<0.05, **p<0.01, *** p<0.001. 
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4.10. Phagocytosis and cathepsin lysosomal leakage precede crystal-induced 
mitochondrial membrane permeability transition  
 
Previous reports have shown that phagocytosis of CaOx crystals leads to lysosomal 
destabilization and lysosomal protease leakage such as cathepsins, which are involved in Nlrp3 
inflammasome activation in response to CaOx crystals.47,180,52 Therefore, we asked the 
questions whether various crystals with different sizes and shapes can trigger lysosomal 
destabilization and lysosomal cathepsin leakage leading to MPT and cell death. To do so, we 
applied 2D TEM and 3D SB-EM imaging techniques to visualizes the internalization of crystals 
by L929 cells. We observed that various crystals (CaOx, silica, MSU and CPPD) are localized 
within endosomal compartments (Figures 28 and 29A-B) after 24 hours of stimulation. These 
observations indicate the involvement of lysosome leakage in stimulated cells with various 
crystals. 
 
CaOx: calcium oxalate, MSU: monosodium urate, CPPD: calcium pyrophosphate dehydrate CsA: 
cyclosporine A, APDC: antioxidant ammonium pyrrolidine dithiocarbamate, SiO2: silica, MFI: 
mean fluorescence intensity, Ppif: peptidylprolyl isomerase F. 
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Figure 28. A 3D reconstruction image. Images were collected from SB-EM and show 
internalization of CaOx crystals (yellow) into intracellular compartments, where they 
fill a major part of the perinuclear cytoplasm. For better visualization, the outer cell 
membrane is shown in green and the nucleus in blue; scale bar 5 µm. CaOx: calcium 
oxalate. 
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To confirm these observations, we used confocal microscopy and stained L929 cells with 
calcein (green color to visualize the live cells) and lysopainter (red color to visualize lysosomes 
within the cell). L929 cells were exposed to CaOx 1 mg/ml, MSU 1 mg/ml, silica 0.5 mg/ml, 
and CPPD 0.5 mg/ml crystals or left untreated (medium control) for 24 hours. After 
stimulation, cells were stained with calcein and lysopainter and subjected to confocal 
microscopy. Unexpectedly, signals were absent in PI positive crystals localized in the 
lysosomal compartment as illustrated by the lysopainter signals (Figure 30A), which is an 
indication for the formation of phagolysosome to digest crystals as foreign bodies. To 
determine the mitochondrial function in the same experiment, we next stained L929 cells with 
calcein and TMRE (red color to visualize live mitochondrial within cells). We found that 
stimulation of cells with various crystals for 24 hours resulted in a loss of TMRE signal (Figure 
30B). These data suggested that upon phagocytosis of crystals regardless of their sizes, 
phagolysosomes are formed in order to eliminate crystals, which is associated with a loss of 
mitochondrial membrane potential and eventually leading to cell death. 
Figure 29. Transmission electron microscopy images from L929 expose to crystal particles. 
(A) 2D images were collected from TEM indicating various sizes and shapes of CaOx (scale bar 
250 nm), silica (scale bar 2 μm), MSU, and CPPD crystals (scale bar 500 nm). (B) L929 cells 
were stimulated with crystals of CaOx, silica, MSU, and CPPD with for 24 hours. Images from 
TEM show crystal phagocytosis. Of note, the crystals present inside the cells were washed out 
during processing leaving behind voids in the cytosol, whereas silica crystals can still be seen. 
CaOx: calcium oxalate, MSU: monosodium urate, CPPD: calcium pyrophosphate dehydrate, 
TEM: transmission electron microscopy, L929: murine fibroblast cell.  
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In addition, we wanted to illustrate lysosome leakage and cell death upon stimulation with 
crystalline particles. To do this, we used lysotracker (green color to visualize the live lysosomes 
within cells) and PI (red color to detect DNA and cell death). L929 cells were treated with 
CaOx 1 mg/ml, MSU 1 mg/ml, silica 0.5 mg/ml, and CPPD 0.5 mg/ml crystals for 24 hours, 
and stained with lysotracker for confocal microscopy. Interestingly, we found that the 
lysotracker signals were absent in PI positive cells and lysotracker positive signals as well as 
no PIs positivity were observed in the medium control (Figure 31), indicating phagolysosome 
rupture and cell death in response to crystals (PI positive cells). 
 
 
 
A 
B 
Figure 30. Confocal images from L929 cells expose to crystal particles. (A) L292 cells were 
stimulated with CaOx, silica, MSU and CPPD crystals for 24 hours and cells stained with calcein 
for live cells and lysopaintaer to visualize lysosome. (B) L292 cells were stimulated with CaOx, 
silica, MSU and CPPD crystals for 24 hours. Afterwards, cells were stained with calcein for live 
cells and TMRE to visualize the function of mitochondria. CaOx: calcium oxalate, MSU: 
monosodium urate, CPPD: calcium pyrophosphate dehydrate. 
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Figure 31. Confocal images from L929 cells stain with lysotracker and PI. L292 cells were 
exposed to CaOx, silica, MSU, and CPPD for 24 hours and cells stained with lysotracker to visualize 
live lysosomes and PI to show cell death. CaOx: calcium oxalate, MSU: monosodium urate, CPPD: 
calcium pyrophosphate dehydrate. 
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Next, we blocked phagocytosis using CytD and cathepsin using CA074Me. We pretreated 
L929 cells with CytD (5 and 10 µM) or CA074Me (10 and 20 µM) for 30 minutes prior to 
stimulation with CaOx 1 mg/ml, MSU 1 mg/ml, silica 0.5 mg/ml, and CPPD 0.5 mg/ml crystals 
for 24 hours. We observed a significant reduction of the PI signals as well as LDH release in 
stimulated cells pre-treated with CytD or CA074Me in a dose-dependent manner compared to 
the control group (Figure 32A-D). Taken together, we conclude that crystals are taken up by 
cells via phagocytosis into intracellular phagolysosome compartments, which leads to 
lysosomal cathepsin leakage as upstream events to crystal-induced MPT and necroptosis 
induced-cell death in L929 cells. 
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Figure 32. Cell death analysis of L929 cells expose to crystal particles in absence or 
presence of a cathepsin inhibitor. A-B: L929 cells were pre-treated with CytD (5 and 10 
μM) prior to stimulation with various crystals. (A) Cells were stained with PI and then 
quantified. Results are expressed as MFI (n=10-12). (B) Cell death was measured using a LDH 
assay kit (n=4-6). (C-D) L929 cells were pre-treated with CA074Me (10 and 20 μM) prior to 
stimulate with crystals. (C) Cells were stained with PI and quantified. Results are expressed as 
MFI (n=10-12). (D) LDH assay was used to determined cytotoxicity (n=4-6).  Data are 
representative of three independent experiments. One-way ANOVA was used to analyze data 
and are expressed as mean ± SEM.*p<0.05, **p<0.001, *** p<0.001 vs vehicle. CytD: 
cytochalasin D, PI: propidium iodide, MFI: mean fluorescent intensity. 
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4.11. Mitochondrial damage involves in CaOx crystal-induced acute kidney injury 
 
To confirm our in-vitro data also in-vivo, we employed an AKI model by injecting sodium 
oxalate i.p. into mice that leads to intrarenal CaOx crystal deposition and AKI47,16,181. After 
induction of AKI, mice were sacrificed after 24 hours and kidneys fixed and subjected to 
Pizzolato and H&E staining, as well as ex-vivo kidney micro-computed tomography. We 
observed the formation of tubular plugs due to CaOx crystal deposition within proximal and 
distal tubules in Pizzolato and H&E staining compared to control mice (Figure 33A-D). 
 
 
Figure 33. Deposition of CaOx crystals inside proximal and distal tubules. (A and 
C) Pizzolato and H&E staining indicate no crystal deposition in control mice (B) but 
the presence of diffuse intrarenal crystals in mice with acute oxalate nephropathye after 
24 hours. (D) Crystals (white arrows) can be seen in polarized light background, which 
is associated with tubule injury (black arrows) in mice with acute oxalate nephropathy 
after 24 hours. H&E: hematoxylin and eosin. 
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The images collected from SB-EM sections showed large crystal plugs and some smaller 
crystals inside epithelial cells of the thick ascending limb of the outer medulla (Figure 34A-C). 
We also investigated mitochondrial morphological abnormalities in injured and unaffected 
kidneys using TEM. We observed mitochondrial ballooning in renal epithelial cells from AKI 
mice (Figures 34A-C), whereas tubular segments from healthy mice represented with and 
normal mitochondria (Figure 34A-C). TEM showed loss of inner membrane cristae ballooning 
as signs of MPT, water influx, and mitochondrial abnormality in mice with acute oxalate 
nephropathy (Figure 35A-C). 
 
 
 
 
 
A                                                                          B                                                     C 
Figure 34. 3D images of the mouse kidney with oxalate nephropathy. (A) 3D and SB-EM image 
of the kidney from a mouse with oxalate nephropathy shows a normal segment of a distal tubule 
(e frame), whereas a segment of the same tubule obstructed with a crystal (f frame). (B) Left frame 
(e) with more magnification shows normal and intact mitochondria (white arrows) at the 
basolateral membrane of distal tubule. (C) Right frame with more magnification shows a crystal 
plug inside the tubular epithelial cells (asterisk) in the tubule lumen and many intracellular crystals 
(black arrows), which is associatied with mitochondrial damage (white arrows). 
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4.12. Ppif-deficiency attenuates CaOx crystal-induced acute kidney injury 
 
The next question was whether Ppif and mitochondrial permeability transition contribute to 
crystalline AKI. We employed acute oxalate nephropathy in wild-type and Ppif-deficient mice. 
First, we checked crystals deposition in wild-type and Ppif-deficient mice and observed that 
CaOx crystal deposits did not vary between both wild-type and deficient mice (Figure 36A). 
In addition, we determined functional parameters of crystalline AKI such as plasma creatinine 
levels, and structural parameters of kidney injury including PAS and TUNEL staining. As 
shown in Figure 36B-F, tubular injury and necrosis as well as TUNEL positive cells were 
significantly reduced in Ppif-deficient mice compared to wild-type mice (Figure 36B-F). This 
indicate that CaOx crystal-induced cell death involves Ppif-driven MPT-RN in acute oxalate 
nephropathy. 
 
Figure 35. TEM images from the kidney show mitochondrial damage (A), (C) Images collected 
from TEM demonstrate the presence of injured mitochondria as indicate by loss of cristae, the 
presence of lucent matrix, and swollen mitochondria (white arrows) in proximity to intrarenal 
crystals in mice with acute oxalate nephropathy. (B) Intact mitochondria in control mice. Scale bar 
A: 1 μm, B-C: 250 nm. TEM: transmission electron microscopy. 
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4.13. Mitochondrial membrane permeability transition-related necrosis and 
necroptosis both contribute to CaOx crystal cytotoxicity 
 
To check the effect between crystal-induced MPT-RN and necroptosis in oxalate crystal-
induced AKI, we induced acute oxalate nephropathy in mice with single versus dual genetic 
deletion of Ppif and Mlkl. We observed that oxalate exposure induced the same amounts of 
CaOx crystal deposits in all mouse strains (Figure 36A).  Mlkl-deficient mice showed similar 
protection from AKI and tubular damage compared to Ppif deficient mice (Figure 36B-F). Ppif 
-and Mlkl-double deficient mice showed a significant additive protection on tubular injury 
compared to either Ppif -or Mlkl-single deficient mice. However, plasma creatinine levels or 
the number of TUNEL positive cells  did not reduce in double deficiency mice (Figure 36B-
F). We conclude that both MPT-RN and necroptosis are involved. Moreover, their partial 
protective effect in crystalline AKI suggests a interlink of both signaling pathways in-vivo. 
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Figure 36. Acute oxalate nephropathy attenuates in Ppif- and Mlkl-deficient mice. (A) 
Inducing acute oxalate nephropathy in wild-type and  Ppif- and Mlkl-deficient or Ppif/Mlkl-
double-deficient mice with the same background showed identical amounts of renal CaOx 
crystal deposition after 24 hours as quantified by morphometry of  Pizzolato-stained kidney 
sections. B-D: Plasma creatinine level increased in wild-type mice with acute oxalate 
nephropathy (B), as well as tubular injury (C), and TUNEL positive cells (D), which were 
reduced in the deficient mice. (E) PAS staining indicates tubular damage at the 
corticomedullary junction in wild-type mice. Original image magnification: x100. (F) TUNEL 
staining shows dead cells in red, with counterstaining for laminin in green and cell nuclei 
DAPI, in white. Original image magnification: x 200. Data are expressed as means ± SEM 
from 6-9 mice in each group. One-way ANOVA with post-hoc Bonferroni`s correction was 
used to analyze data. Data are presented as mean  SEM * p<0.05, *** p<0.001 versus 
oxalate-treated wild-type mice. Ppif: peptidyl-prolyl cis-trans isomerase, Mlkl: mixed lineage 
kinase domain like pseudokinase, CaOx: calcium oxalate, TUNEL: Terminal 
deoxynucleotidyl transferase dUTP nick end labelling. C = cortex, OSOM = outer stripe of 
the medulla, ISOM = inner stripe of the medulla. 
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4.14. Mitochondrial membrane permeability transition-related necrosis and 
necroptosis inhibitors reduce crystalline organ damage  
 
We sought to investigate whether Ppif can be used as therapy for acute oxalate nephropathy 
and to investigate the potential of inhibiting both MPT-RN and necroptosis. To do so, wild-
type mice were injected with the MPTinhibitor  CsA and the necroptosis inhibitor Nec1s or 
both in combination. We observed that inducing acute oxalate nephropathy in mice resulted in 
equal amounts of CaOx crystal deposition (Figure 37A). Single treatment with CsA and Nec1s 
showed partial effects in reducing plasma creatinine levels (Figure 37B), a marker of renal 
function, as well as tubular injury and TUNEL positive cells (Figure 37C-E). However, 
inhibiting both MPT and necroptosis at the same time had only an effect on the number of 
TUNEL positive cells but not on renal function and tubular injury compared to the single-
treated groups of mice (Figure 37B-F). Our data show that dual inhibition of MPT and 
necroptosis can have some additional protective effects on crystal-induced organ injury, and 
suggest the involvement of both cell death pathways in-vivo. 
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Figure 37. Nec1s and CsA inhibitors attenuate acute oxalate-induced kidney injury. A-C: 
Acute oxalate nephropathy was induced in wild-type mice, which were treated with vehicle, 
the MPT inhibitor (CsA, 2 mg/kg) or the Rip1 inhibitor Nec1s or in combination of CsA with 
Nec-1s. Pizzolato-staining revealed the same amounts of CaOx crystal deposition after 24 
hours (A). Treatment with the single inhibitors or dual blockade significantly reduced the 
plasma creatinine levels (B) and tubular injury (C), as well as showed less TUNEL positive 
cells in kidney samples (D). PAS staining showed tubular injury at the corticomedullary 
junction in wild-type mice. Original image magnification: x100 (E upper panel). (F) TUNEL 
staining visualized dead cells in red, with counterstaining for laminin in green and cell nuclei 
DAPI, in white. Original image magnification: x200 (E lower panel). Data are presented as 
means ± SEM from 5-7 mice in each group. One-way ANOVA with post-hoc Bonferroni`s 
correction was used to analyze data. * p<0.05, ** p<0.01, *** p<0.001 versus vehicle-treated 
mice. CsA: cyclosporine A, MPT: membrane permeability transition, Nec1s: necrostatin-1s, 
CaOx: calcium oxalate, TUNEL: Terminal deoxynucleotidyl transferase dUTP nick end 
labelling. C = cortex, OSOM = outer stripe of the medulla, ISOM = inner stripe of the medulla. 
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4.15. Involvement of MPT in human tubular cells 
 
To confirm and validate our mouse results in human cells, we used HK2 and CD24/CD133+ 
epithelial progenitor cells, which were isolated from healthy human kidneys that are known to 
contribute to the turnover of tubular epithelial cells and their regeneration after acute 
injury.182,183 HK2 cells were pre-treated with the MPT inhibitor CsA, the ROS inhibitor APDC, 
the phagocytosis inhibitor CytD and the cathepsin inhibitor CAO74Me for 30 minutes prior to 
stimulation with CaOx, silica, MSU, and CPPD crystals for 24 hours. We saw a significant 
reduction of PI positive signals in treated cells compared to the vehicle group (Figure 38A-D). 
These data indicate that MPT is also involved in crystal cytotoxicity in human cells. 
Furthermore, we used CD24/CD133+ epithelial progenitor cells and pre-treated them with the 
MPT inhibitor CsA, the ROS inhibitor APDC, the phagocytosis inhibitor CytD and the 
cathepsin inhibitor CAO74Me for 30 minutes prior to stimulation with CaOx, silica, MSU, and 
CPPD crystals for 24 hours. We observed a significant reduction in PI positive signals after 
pre-treating cells with various inhibitors. We conclude that the MPT pathway is involved in 
crystal-induced cell death and injury in human cells (Figure 39A-D). 
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Figure 38. Cell death analysis of HK2 cells stimulated with crystalline particles in the 
presence of various inhibitors. (A-D) HK2 cells were pre-treated with different inhibitors as 
mentioned before and stimulation with 1 mg/ml CaOx, 0.5 mg/ml silica, 0.5 mg/ml MSU and 0.5 
mg/ml CPPD crystals. Cells were stained with the dye PI. Results were quantified and expressed 
as MFI (n =10-12). Data are representative of three independent experiments. One-way ANOVA 
was used to analyze data and are presented as mean SEM. *** p<0.001 vs vehicle. CaOx: calcium 
oxalate, MSU: monosodium urate, CPPD: calcium pyrophosphate dehydrate. MFI: mean 
fluorescent intensity.  
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Figure 39. Cell death analysis of primary human renal progenitor cells stimulated with 
crystal particles. (A-D) Primary renal human progenitor cells were pre-treated with vehicle, CsA 
(1 µM), APDC (200 µM), CytD (10 µM), and CA074Me (20 µM) prior to stimulation with 1 
mg/ml CaOx, 0.25 mg/ml silica, 0.5 mg/ml MSU and 0.5 mg/ml CPPD crystals. Cells were stained 
with PI andiImages were quantified and expressed as MFI (n=3-4). Data is representative from 
three independent experiments. One-way ANOVA was used to analyze data and are presented as 
mean ± SEM. *** p<0.001 vs vehicle. CaOx: calcium oxalate, MSU: monosodium urate, CPPD: 
calcium pyrophosphate dehydrate, APDC: (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate;  
CytD: Cytochalasin D, CsA: cyclosporin A.  
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5. Discussion 
 
In this thesis project we had hypothesized that: 
1. Acute tissue injury leading to progressive organ damage is associated with 
increased expression of necroptosis-related genes.  
 
2. Environmental and metabolic crystals, regardless of their shape and size induce 
necroptosis in primary and immortalize human and mouse renal tubular cells. 
 
3. Crystalline particles induce MPT as an alternative form of cell death and drive 
organ injury in vivo. 
 
 
The molecular events of kidney injury are associated with cell death and inflammation, i.e. 
necroinflammation. Cell death pathways can be distinguished by morphology or caspase 
activity. For example, apoptosis is a non-immunogenic cell death pathway due to the formation 
of apoptotic bodies and their removal by immune cells, whereas regulated necrosis pathways 
are highly immunogenic and able to trigger inflammation. Necrosis was thought to be an 
uncontrolled form of cell death but meanwhile many studies show that necrosis is usually 
highly regulated 117Necrotic cells release DAMPs, which induce the secretion of inflammatory 
cytokines. In turn, cytokines can induce regulated-necrosis, which results in an 
autoamplification loop named necroinflammation. Necroinflammation is the main event in 
AKI. 16, 108, 184, 47 Our data now show that the mRNA expression levels of Ripk3, Mlkl, and 
cIAP1/2 are significantly increased in three different models of AKI. These observations, 
regardless of the different inducer of injury, raise the question whether the necroptosis pathway 
is involved in renal tubular damage or not. However, we saw different patterns of expression 
levels of regulated-necrosis-related genes, including, Tnfr1, Ripk1, Casp8, Fadd, Ppif (CypD), 
Casp1, Nlrp3, and Parp1. For example, Nlrp3 and Casp1 are significantly increased in IRI and 
cisplatin, whereas they did not induce acute oxalate nephropathy. Although Nlrp3- and Casp1-
deficient mice show less injury compared to wild-type mice. Interestingly, Ppif (CypD) did not 
change in IRI and acute oxalate mice, but was significantly down-regulated in cisplatin model. 
Ppif -deficient mice were protected from IRI. In spite of that, Linkermann, et al, demonstrated 
that Ppif -deficient mice showed significantly prolonged survival in a lethal IRI model 
compared to wild-type mice.111 In addition, Ppif-deficient mice exhibited improvement of renal 
function and less kidney damage.111 Moreover, Gpx4 mRNA expression did not change in all 
three AKI models. Although in previous studies, the inhibition of ferroptosis with a new 
  Discussion                                                                                                                                        84 
 ________________________________________________________________________________  
generation of a third-generation ferrostatin (SRS16-86) drug as well as Ppif-deficient mice 
showed less kidney injury.159, 160 Furthermore, we observed that Parp1, a mediator of the 
parthanatos pathway, did not change in any of the AKI models. Little is known about the 
association of the parthanatos with kidney injury. However, one study showed that Parp1 
reduced graft rejection in kidney transplantation patients and could serve as a serum 
biomarker185. It is worth mentioning that, the two major proteins Ripk3 and Mlkl are highly 
induced in renal IRI, acute oxalate nephropathy, and cisplatin models at mRNA and the protein 
level using RT-PCR and immunohistochemistry. However, the contribution of cell death and 
inflammation in CKD is not very clear since chronic tissue injuries are represented by a low 
grade of continuous inflammation as well as more chronic wound healing mechanisms, often 
resulting in tissue atrophy and scaring. Our data now show that Ripk3 and Mlkl transcripts 
significantly increased on day 7 and 14 compared to the control group in chronic oxalate 
nephropathy; however, Mlkl expression levels decreased on day 21 but not Ripk3. These 
observations suggested that firstly the necroptosis pathway could be involved in CKD 
following IRI. 
Secondly, necroptosis inhibitors may give maximal protection during early phase of injury. 
Although functional studies are needed to check the role of necroptosis in CKD. Interestingly, 
Nlrp3 and Casp1 were highly induced at day 7, 14, and 21. These high expression levels could 
be due to macrophage infiltration and different state of these specialized immune cells. Indeed, 
our group showed that the Nlrp3 inhibitor b-hydroxybutyrate, as well as lack of Nlrp3, 
attenuated nephrocalcinosis-related CKD in mice186. Meanwhile, Ppif (CypD) mRNA is 
significantly down-regulated at all three-time points, which could serve as a negative regulator 
of the MPT pathway in chronic oxalate nephropathy but functional studies are required to 
confirm the present data. Nonetheless, it is noticeable that only mRNA profiling studies may 
not represent the functional role of each gene in the process of the diseases with high 
complexity as well as multi-interaction pathway responses to a particular injury. However, our 
data showed a new sight into how regulated-necrosis-related genes respond to tissue injury, 
and it could be useful to develop a novel therapy for the tissue and organ injury but not limited 
to only kidney related-diseases. 
Crystals or crystalline particles induce NLRP3 inflammasome complex formation; hence 
activate inflammation and the necroinflammation loop187. Cholesterol crystals phagocyte by 
human monocyte and macrophage activate NLRP3 result in IL-1β secretion.188 In addition, 
Duewell, et al. showed that cholesterol crystals contribute to the development of  
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atherosclerosis in mice.189 The deposition of MSU and CPPD crystals associated with gout and 
pseudogout, respectively, trigger Nlrp3 inflammasome activation, resulting in acute and 
chronic inflammation.180 CaOx crystals have been described to be involved in acute kidney 
damage through activation of the NLRP3 inflammasome in renal dendritic cells, which is 
associated with the release of IL‑1β and inflammation.47 A similar mechanism has been shown 
for other crystals including silica, asbestos.52,190, TiO2
191, and CaP192 although inflammasome 
formation can also lead to activation of Casp1, which could result in activation of the pyroptosis 
pathway.193, 194 However, our data now show that blocking caspases did not prevent 
cytotoxicity of crystalline particles. These observations indicate that crystal or crystalline 
particles induced-cell death is independent of caspase activity. In addition, FACS analysis 
showed the involvement of primary necrosis as predominant form of cell death in crystal or 
crystalline particles cytotoxicity. Our group recently reported that crystal or crystalline particle 
induced-cell death occurs through activation of the necroptosis pathway in primary mouse 
tubular epithelial cells.16 Furthermore, the involvement of necroptosis in acute oxalate 
nephropathy was confirmed using Mlkl-deficient mice.16 Our data now reveal that blocking 
core proteins of the necroptosis pathway results in partial protection in crystal or crystalline 
particle cytotoxicity regardless of their sizes, shapes and origin (Figure 40). RIPK1 is an 
upstream kinase protein of RIPK3 of the necroptosis signaling pathway, which is considered 
to be the initiator of this pathway by inducing RIPK3 phosphorylation (Figure 40). The main 
reason why RIPK1 activity is believed to be needed for necroptosis activation is that blocking 
RIPK1 with Nec1s could effectively prevents necroptosis and shows a protective effect in 
various animal disease models.195,196,197,198,199 Interestingly, Conor J. Kearney, et al. 
demonstrated that silencing Ripk1 using siRNA at mRNA level does not suppress but activates 
necroptosis in L929 cells treated with TNF-α and zVAD, which means that RIPK1 can act as 
an inhibitor rather than an initiator of necroptosis.200 Moreover, enzymatic post-translational 
modifications of RIPK1 play a crucial role in the suppression of necroptosis. For example, 
ubiquitination of RIPK1 prevented necroptosis.201 These data strongly suggested that RIPK1 
can behave completely different depending on the biological conditions. However, our data 
revealed that inhibition of RIPK1 using Nec1s results in the reduction of crystal or crystalline 
particle cytotoxicity in renal human tubular cells (Figure 40). However, it would be interesting 
to study different aspects of RIPK1 in crystalline particle cytotoxicity. In addition, we saw that 
pretreatment of cells with the RIPK3 inhibitor dabrafenib prevented crystal or crystalline 
particle-induced cell death (Figure 40). Moreover, silencing RIPK3 using specific siRNA 
showed the same trends of protection. MLKL is a crucial protein in the necroptosis signalling 
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pathway, which is also responsible for the execution of necroptosis-dependent cell death.202 It 
was reported that MLKL gets phosphorylated through RIPK3 activation.103 Furthermore, upon  
necroptosis activation, conformational switching of the pseudokinase domain triggers human 
MLKL tetramerization, which is needed for the execution of cell death.203 Interestingly, MLKL 
activation can trigger NLRP3 inflammasome activation and release of IL-1β in 
macrophages.204 Our data show that depletion of MLKL with NSA or Mlkl-deficient mice 
partially prevented crystalline particle-induced cell death (Figure 40).  Furthermore, many 
studies showed that sizes and shapes of particles are critical in responding to inflammatory 
signals, for example, nanoparticles with different sizes and shapes can have broad cytotoxicity 
effects in various cell types as well as animal models.205 Interestingly, silica particles with a 
range of 30 nm to 1000 nm show more cytotoxic effect on cells, including lysosomal 
destabilization, cell death, and IL-1β secretion compared to larger 3000 nm - 10000 nm 
particles.206 Muñoz LE, et al. showed that nanoparticles lead to neutrophil NETosis dependent 
on the size of particles.173  The authors in this study used nanodiamonds ranging between 10 
nm to 1000 nm and polystyrene ranging between 40 nm to 1000 nm. They observed that 
aggregated NETs formation happens only in response to small sized nanoparticles. Besides 
that, human epithelial (HeLa) cells exposed to small nanodiamond particles (10 nm) showed 
the most cytotoxic effect associated with vacuolization and formation of structures resembling 
apoptotic subcellular microvesicles. In addition, they observed that nuclear material released 
into ACMV like blebs, whereas nanodiamond particles with more than 50 nm did not have a 
cytotoxic effect. However, zVAD-FMK, a pan-caspase inhibitor, did not abolish the cytotoxic 
effects of small sized nanoparticles (10 nm). The authors concluded that nanoparticles directly 
damage the plasma membrane without activation of apoptosis in epithelial cells.173 However, 
it is well-established that apoptosis does not lead to plasma membrane damage or rupture. 
Therefore, it is not yet clear whether small nanodiamond particles induce cell death through 
only cell membrane damage or whether they can activate the programmed cell death pathways. 
CaP bioceramics have been used as bone substitutes for several years. HA particles are 
dispersed within an amorphous CaP matrix and CaP particles can be released during 
remodeling of bone and lead to inflammation. Of note, HA particles with different sizes can 
have diverse effects on inflammatory markers.207,208 In the present study, we used crystals or 
crystalline particles with significantly differences in their sizes as well as shapes. Interestingly, 
we saw that regardless of their sizes and shapes, all crystalline particles induced necroptosis in 
human and mouse renal tubular epithelial cells but induced different effects of protection. 
These observations strongly suggested that other forms of cell death could be involved in 
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crystal or crystalline particle-induced cell death. Furthermore, we saw that the inhibition of 
actin polymerization significantly reduced the cytotoxic effects of crystalline particles 
indicating that phagocytosis is required for crystalline particle-induced cell death (Figure 40). 
Our data demonstrate that crystal or crystalline particles irrespective of origin (environmental 
or metabolic), sizes, and shapes are associated with necroptosis. These findings show that 
RIPK1, RIPK3, and MLKL could serve as potential molecular targets to limit tissue damage 
in silicosis, TiO2-induced lung injury, CaP-related bone implantation as in occupational-
related diseases, and cholesterol embolism, gout, pseudogout, and oxalate nephropathy, as in 
metabolic-related disorders.  
As mentioned earlier, our data show that crystal- or crystalline particle-induced cell death 
involves caspase independent mechanisms; however, inhibition of necroptosis showed only a 
partial protective effect. Therefore, we had hypothesized that other regulated necrosis pathways 
might be involved in crystal cytotoxicity. Indeed, reports have shown that CaOx crystal 
particles can alter the mitochondrial membrane potential, and a process that can be reversed by 
using the Ppif inhibitor CsA.209 In addition, CsA injected into hyperoxaluric rats reduced 
calcium crystallization compared to healthy rats.209 Moreover, MPT-RN is involved in renal 
IRI as well as cisplatin-induced kidney injury.210 Indeed, Ppif-deficient mice showed less 
kidney injury in acute oxalate nephropathy compared to wild-type mice. Besides that, CsA 
injected into wild-type mice showed similar protection. In addition, proteins located on the 
outer and inner mitochondrial membranes play an important role in inflammation and cell 
death.211, 117, 212 MPT appears to be controlled by Ppif protein, which can promote opening of 
pores during the activation of MPT.213 In addition, Ppif can drive the breakdown of MOMP, 
water influx, mitochondrial swelling, loss of cristae, ROS production, and eventually, 
mitochondrial and cellular rupture211,117 In particular, Ppif-dependent mitochondrial damage is 
associated with proximal tubules function after hypoxic and ischemic injury.214 Our data show 
that phagocytosis of CaOx crystals can have a direct Ppif-driven cytotoxic effect and lead to 
MPT-RN in freshly isolated primary tubular epithelial cells (Figure 40). Furthermore, the same 
mechanism of regulated-cell death contributes to acute oxalate nephropathy. Interestingly, we 
did not observe any differences in crystal deposition in Ppif-deficient mice compared to wild-
type mice. These findings suggested that Ppif does not play a role in crystals deposition in acute 
oxalate nephropathy. However, a previous study has reported that inhibition of Ppif in rats 
could limit the renal calcium crystallization215, although ethylene glycol had been used to 
induce calcium crystallization but this might be due to different mechanisms. It is worth 
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mentioning that a recent study reported that genetic differences in the background of C57BL/6 
mouse substrains could have diverse effects on kidney crystal depositions.216 The molecular 
mechanisms of crystal or crystalline particle-induced MPT-RN have not been completely 
understood. Our data on 2D TEM as well as 3D reconstruction revealed that renal epithelial 
tubular cells can phagocytose crystalline particles, which leads to formation of phagolysosomes 
(Figure 40). Since crystalline particles are difficult to digest inside phagolysosome, they rather 
induce lysosomal leakage and trigger the release of cathepsins (Figure 40). It is known that 
cathepsins are released as a consequence of lysosomal damage and are associated with crystal-
induced activation of the NLRP3 inflammasome.33,47 Indeed, our data demonstrate that 
blocking cathepsins using a chemical inhibitor partially reduced crystal- or crystalline particle-
induced MPT-RN (Figure 40). However, reports have shown that cathepsins can reduce 
regulated-necrosis in mouse macrophages through Rip1 kinase cleavage. Since different 
cathepsins have been described, further studies are needed to rule out the function of each 
cathepsin. Interestingly, preventing the internalization of crystalline particles in renal epithelial 
tubular cells significantly reduced ROS production and cell necrosis, as well as an improved 
MOMP. These findings suggested that phagocytosis of crystals is an essential step in crystal or 
crystalline particle-induced MPT-RN. In line with previous reports, ROS production is a 
critical step in MPT-related regulated necrosis.211,117 Our data now reveal that blocking ROS 
production can effectively reduce crystal-induced MPT-related regulated necrosis as well as  
loss of MOMP (Figure 40). Interestingly, blocking Ppif with CsA as well as specific siRNA 
against Ppif at mRNA level significantly reduced crystal-induced MPT-related regulated 
necrosis, ROS production, and loss of MOMP. Since our previous data indicate the 
involvement of necroptosis in crystal or crystalline particle-induced cell death, we were 
interested in checking what could be the potential contribution of MLKL in MPT-RN. It was 
reported that widespread mitochondrial depletion does not affect RIPK3-dependent necroptotic 
cell death.217 However, recent studies showed the involvement of the necroptosis pathway 
through mitochondrial function in different conditions.218,219 Interestingly, one study showed 
that pMLKL translocates to the mitochondrial membrane and contributes to cell death.220 Our 
data now show that Ppif -and Mlkl-deficient mice did not give consistent results in acute oxalate 
nephropathy. These findings indicate that both necroptosis and MPT-RN contribute to crystal 
or crystalline particle-induced tissue injury in the context of AKI. One recent study showed 
that activation of necroptosis through the TNF-α signaling pathway in mouse microvascular 
endothelial cells leads to cell death and transplant rejection in mice, which could be attenuated 
by inhibiting Ppif.221 However, the role of cathepsins was not considered in this study despite 
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their important role in crystal-induced cell death and necroptosis. In addition, MPT activation 
in crystal or crystalline particles-induced cell death is completely different from TNFa 
signalling; therefore it might lead to different results and observations. Our data now show the 
contribution of both necroptosis and MPT-RN in crystal-induced cell death and organ injury. 
These finding could contribute to the development of novel therapies in crystal or crystalline 
particle-induced cell death as well as organ injury. 
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Figure 40. Schematic synthesis of necroptosis and MPT pathways. Crystal particles are taken 
up by renal epithelial cells and form phagolysosomes, which then rupture due to a lack of capacity 
of the epithelial cell to digest the crystalline particles. Cathepsins could release from lysosomal 
rupture into the cytosol and regulate mitochondrial permeability transition as well as necroptosis. 
Upon RIPK and RIPK3 phosphorylation, MLKL is activated and translocates to the plasma 
membrane and mitochondrial membrane resulting in cell rupture and regulated necrosis. On the 
other hand, crystalline particles can activate the MPT pathway leading to cell death. In this process, 
ROS production due to mitochondrial damage promotes the formation of the necrosome. MPT: 
membrane permeability transition, RIPK1/3: receptor-interacting serine/threonine-protein kinase 
1/3, MLKL: mixed lineage kinase domain like pseudokinase ROS: reactive oxygen species. 
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6. Study limitations 
 
We have encountered various limitations in the present study. Since we used two systems in-
vitro and in-vivo to confirm our results, we had limitations related to both methods.  
One part of the study was aimed to determine the cytotoxic effects of crystalline particles in-
vitro. The list of limitations are as follow: 
 We could only study a small range of different concentrations of crystal particles due 
to their physical properties. This means that if we would have used higher 
concentrations crystal particles would have covered all cells and eventually resulted in 
physical and unwanted damage. 
 In our in-vitro study, we only used human or mouse non-immune cells in the concept 
of kidney injury. However, it would be useful to also confirm the data in a broader 
range of cell types. 
 Due to the high cytotoxic effects of crystalline particles, we could only perform all 
experiments within 24 hours, which may not optimally mimic crystal-induced tissue 
injury under physiological conditions in-vivo. 
One of the main limitations of the in-vivo system was that we could perform only a single 
mouse model of acute oxalate nephropathy, which allows us to check the involvement of 
Ppif and Mlkl proteins in the concept of CaOx-dependent kidney damage.We were unable 
to carry out other mouse disease models for related to the above mentioned types of 
crystalline particles such as acute gouty arthritis, silicosis, and cholesterol crystal 
embolism; therefore we focussed more on in-vitro experiments. For example, MSU, CPPD, 
silica, TiO2, and cholesterol would have been equally interesting to study in-vivo but would 
have required other ethical agreements, which were not available. Another major limitation 
was that we could not use other human samples to show the importance of our findings in 
human diseases.  
Despite these limitations, we performed all experiments on primary human and mouse cells 
as well as cell lines to show the involvement of necroptosis as well as MPT-RN in crystal 
or crystalline particles cytotoxicity.  
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7. Conclusion 
 
Our data provide new insights into the pathomechanism of crystalline particles in organ failure 
as well as tissue injury. 
The findings of our study have the following potential implications as listed below: 
 The regulated necrosis-related genes, particularly Ripk1, Ripk3, and Mlkl, were highly 
induced in mouse models of AKI as well as CKD, which provided a rationale to test for 
their causal contribution to tissue injury and organ failure. 
 Caspase-dependent cell death pathways do not contribute to crystal-induced 
cytotoxicity. 
 Environmental and metabolite crystalline particles induce necroptosis. 
 Crystalline particles require internalization into the cells via phagocytosis to initiate cell 
death processes. 
 Mitochondrial damage contributes to crystalline particles cytotoxicity. 
 Ppif mediates mitochondrial damage and promotes crystal cytotoxicity. 
 Neutralizing MPT and targeting necroptosis abrogate acute oxalate nephropathy.   
Since the cytotoxic effects of crystal or crystalline particles can lead to acute inflammation, 
cell death, and eventually severe organ failure, understanding the molecular mechanisms of 
crystal-induced tissue injury is crucial. Indeed, our data now reveal that metabolic and 
environmental crystalline particles can activate necroptosis and MPT-RN, and that blocking 
these two cell death pathways can limit the cytotoxicity effect of crystal-induced kidney failure. 
It is likely that the same mechanism is involved in crystal-induced injury in other organs as our 
in-vitro studies with different crystalline microparticles demonstrate. Besides that, our data on 
human progenitor cells showed the same molecular mechanisms on the crystal or crystalline 
particle-induced cell death. 
Taken together, our research highlights the importance of MPT-RN and necroptosis in organ 
and tissue injury in mouse as well as human cells.  Potentially, our data could be useful to 
develop a novel target therapy for occupational job related-diseases as well as metabolic 
crystalline particle-related diseases. 
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Zusammenfassung 
 
Unterschiedliche Kristalle und kristalline Partikel sind mit Krankheitskomplikationen 
assoziiert. Eine unkontrollierte Bildung kristalliner Partikel im Körper führt zur Zell- und 
Organschädigung am betroffenen Ort. Unter anderem führen z.B. Harnsäurekristall (MSU)-
Ablagerungen in Gelenken zur Gichtarthritis sowie Inhalation von Silikonstäuben zur Silikose 
und Cholesterinplaques zur Progression von Atherosklerose. Kristalle führen durch 
Aktivierung der NLR-Familie, NLRP3 und Inflammasom-Formation, welche wiederum IL-1β 
und IL18 Sekretion induzieren, zu Entzündungsprozessen in Geweben. Daten haben gezeigt, 
dass Silikonpartikel in Makrophagen zu Apoptose führen. Unsere Arbeitsgruppe zeigte, dass 
Kristalle zu RIPK1, RIP3 und MLKL vermittelten Nekroptose beitragen. In dieser Studie 
wurden vier unterschiedliche metabolische Kristalle (z.B. Kalziumoxalat (CaOx), MSU, 
Calcium Pyrophosphat Dihydrat (CPPD), und Cystein) genutzt um die zyototoxischen Effekte 
an Zellen und Organen zu untersuchen. Zwei Fragen blieben jedoch unklar: 1. Können 
Kristallpartikel aus der Umwelt zu Zellnekroptose führen? und 2. Ist ein anderer 
Zelltodmechanismus am Kristall-induzierten Zelltod beteiligt? Zur Beantwortung der ersten 
Frage selektierten wir unterschiedliche Kristalle und kristalline Partikel, darunter Silikone, 
Titanium Oxide, Cholesterol und Calcium Phosphat als Umwelt-assoziierte Kristalle, sowie 
MSU, CaOx, Cholesterol und Calcium Phosphat als metabolische Kristalle. 
Zunächst untersuchten wir die Expression von Zelltod-regulierenden Genen in 
unterschiedlichen Tiermodellen. Wir beobachteten, dass RIK3 und MLKL sowohl im 
chronischen Modell der Oxalat-Nephropathie sowie akut-chronischem Ischemie-Reperfusion-
Modell stark hochreguliert waren. Im Anschluss wurde in einer Reihe von Experimenten, die 
Beteiligung des Nekroptose-Signalwegs an Kristall-induziertem Zelltod evaluiert. 
Pharmakologische Inhibition der wichtigsten Proteine (RIPK1, RIPK3, MLKL) der 
Nekroptose resultierte in Zelltodverringerung. Passend zu diesen Beobachtungen konnte 
gezeigt werden, dass Mlkl-Knockdown und RIPK3-Runterregulierung mittels siRNA in 
primären Tubularzellen ebenfalls Zelltod reduziert. Um zu überprüfen, ob die intrazelluläre 
Aufnahme von Kristallen erforderlich ist, um den nekrotischen Zelltod zu induzieren, haben 
wir die Phagozytose mit CytD blockiert.Interessanterweise haben wir gesehen, dass die 
Hemmung der Phagozytose den Zelltod als Reaktion auf Kristalle signifikant verringert. Die 
gezielte Inhibierung der Nekroptose führte jedoch nicht zu einem vollständigen Blockade des 
Kristall-induzierten Zelltod. Aus diesem Grund spekulierten wir, dass ein anderer Zelltodweg 
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beteiligt ist. Frühere Studien zeigten eine mögliche Beteiligung für den mitochondrial 
Permiabilität-vermittelten (MPT) Zelltod-Signalweg.. Wir stellten die Hypothese auf, dass der 
MPT Zelltod eine Rolle bei der Kristall-induzierten Zytotoxizität spielen könnte. In der Tat 
bestätigen die Daten, dass MPT am durch Kristallpartikel-induzierten Zelltod beteiligt ist. 
Zusammenfassend zeigen unsere Ergebnisse, dass Nekroptose und MPT-RN eine wichtige 
Rolle beim durch Kristall- oder Kristallpartikel-induzierten Zelltod in vitro sowie bei der 
akuten Oxalatnephropathie in vivo spielen. Diese Ergebnisse könnten bei der Entwicklung 
neuer Therpaien für Erkrankungen im Zusammenhang mit Kristallen oder kristallinen Partikeln 
hilfreich sein. 
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Summary 
Various crystals or crystalline particles are associated with clinical complications. The 
formation of crystalline particles within the wrong place of the body can result in cell injury 
and organ failure. For example, monosodium urate (MSU) deposition within joints cause gouty 
arthritis, deposition of CaOx in renal tubular compartment results in kidney injury, silica dust 
inhalation is associated with silicosis, and cholesterol promotes plaque and atherosclerosis 
progression. It is well-known that crystals can induce inflammation through activation of the 
NLR family, pyrin domain containing 3 (NLRP3), and inflammasome formation, which trigger 
interleukin 1 beta (IL-1β) and interleukin 18 (IL18) secretion. It has been shown that silica 
particles trigger apoptosis in macrophages. Although, our group showed that crystals cause 
necroptosis driven by receptor-interacting protein kinase 1 (RIPK1), receptor-interacting 
protein kinase 3 (RIPK3), and mixed lineage kinase domain-like pseudokinase (MLKL) 
proteins. In this study, four different metabolic crystals, including calcium oxalate (CaOx), 
MSU, calcium pyrophosphate dihydrate (CPPD), and cystine were used to show the cytotoxic 
effects on cells and organs. However, two main questions remained unclear; 1. Do 
environmental crystal particles induce necroptosis? And 2. Is another cell death pathway 
involved in crystal-induced cell death?  To answer the first question, different crystal or 
crystalline particles such as silica, titanium dioxide (TiO2), cholesterol, and calcium phosphate 
(CaP) as environmental and MSU, CaOx, cholesterol, and CaP as metabolic crystalline 
particles were selected. Firstly, the expression level of regulated necrosis-related genes in 
different models was determined. We observed that Ripk3 and Mlkl were highly upregulated 
in acute and chronic oxalate nephropathy as well as acute and chronic ischemia-reperfusion 
injury as expected. Next, in a series of in-vitro and in-vivo experiments, the involvement of 
necroptosis was evaluated in response to environmental and metabolic crystalline particles. 
Pharmacological inhibition of Ripk1, Ripk3, and Mlkl prevented necroptosis cell death. In line 
with this finding using Mlkl-deficient primary renal tubular cells as well as siRNA against 
Ripk3 can reduce cell death and confirm the previous results. To check whether phagocytosis 
of crystals is required for inducing necroptotic cell death, we blocked phagocytosis using CytD. 
Interestingly, we saw that inhibiting phagocytosis significantly decreased cell death in response 
to crystals. However, targeting necroptosis did not result in a complete protection crystal-
induced cell death. Therefore, we speculated that another cell death pathway involved. Previous 
studies showed a potential role for the MPT cell death pathway. Therefore, we hypothesized 
that the MPT pathway could play a role in crystal induce cytotoxicity. Indeed, the data confirm 
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that MPT is involved in crystal particle-induced cell death. Taken together, our findings 
indicate that necroptosis and MPT-RN play an important role in crystal- or crystalline particle-
induced cell death in-vitro as well as acute oxalate nephropathy in-vivo. These findings could 
be useful in developing new therapies for crystal- or crystalline particle-related diseases. 
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